{{多個問題|
{{需要专家关注|subject=医学}}
{{copyedit|time=2012-08-21T15:03:52+00:00}}
{{Rough translation|time=2020-08-18T05:13:13+00:00}}
}}
{{medical}}

{{noteTA
|G1=生命科學
|1 = zh-cn:维生素; zh-tw:維生素; zh-hk:維他命;
}}

{{Infobox drug class
|Synonyms= IUPAC name: (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol
| Name     = 維生素D
| Image    =  Cholecalciferol-3d.png 
| Alt      =
| Caption = [[膽鈣化醇|膽鈣化醇]] (D<sub>3</sub>)
| Uses = 預防[[佝僂病|佝僂病]]、[[骨質疏鬆症|骨質疏鬆症]]、[[維生素D缺乏症|維生素D缺乏症]]
| MeshID = D014807 
| Consumer_Reports =
| ATC_prefix = A11CC
| medicinenet = 
| rxlist = 
| Drugs.com = {{Drugs.com|npp|vitamin-d}}
| Biological_target = {{le|維生素D受體|calcitriol receptor}}
}}

'''維生素D'''（{{lang-en|Vitamin D}}）是一組[[親脂性|親脂性]]類固醇衍生物，是一種[[激素|激素]]的前體，屬於[[脂溶性|脂溶性]][[維生素|維生素]]，負責增加腸道對[[鈣|鈣]]、[[鎂|鎂]]和[[磷酸鹽|磷酸鹽]]的吸收，以及其他多種生物效應<ref name="Holick 2004" />。對人類而言，維生素D中最重要的化合物是維生素D<sub>2</sub>（[[麥角鈣化醇|麥角鈣化醇]]）及維生素D<sub>3</sub>（又稱為[[膽鈣化醇|膽鈣化醇]]）<ref name="Holick_2006">{{cite journal | vauthors = Holick MF | title = High prevalence of vitamin D inadequacy and implications for health | url = https://archive.org/details/sim_mayo-clinic-proceedings_2006-03_81_3/page/353 | journal = Mayo Clinic Proceedings | volume = 81 | issue = 3 | pages = 353–73 | date = March 2006 | pmid = 16529140 | doi = 10.4065/81.3.353 | doi-access = free }}</ref>。維生素D對鈣質於體內平衡和代謝中具有重要作用，可用以預防[[佝僂病|佝僂病]]和「成人骨軟化症」，跟鈣質合用可以預防出現於老年人的[[骨質疏鬆症|骨質疏鬆症]]。此外，對於神經肌肉功能、[[炎症|炎症]]都有功用，還影響許多基因的表達和演譯，調節細胞的增殖、[[轉化_(生物)|轉化]]和[[細胞凋亡|凋亡]]<ref name="FactD">{{cite web |url=http://ods.od.nih.gov/factsheets/vitamind/ |title=Dietary Supplement Fact Sheet: Vitamin D |work=Office of Dietary Supplements (ODS) |publisher=[[National_Institutes_of_Health|National Institutes of Health]] (NIH) |accessdate=2010-04-11 |archive-date=2012-02-13 |archive-url=https://web.archive.org/web/20120213172750/http://ods.od.nih.gov/factsheets/VitaminD/ |dead-url=yes }}</ref>。

維生素D的主要天然來源是取決於透過[[日照|日光照射]]在皮膚表皮的下層的化學反應而合成膽鈣化固醇（特別是[[紫外線#科學上的分類|UVB輻射]]）<ref>{{cite web |first=James |last=MacDonald |title=How Does the Body Make Vitamin D from Sunlight? |website=JSTOR Daily |date=2019-07-18 |url=https://daily.jstor.org/how-does-the-body-make-vitamin-d-from-sunlight/ |access-date=2019-07-22 |archive-date=2020-12-22 |archive-url=https://web.archive.org/web/20201222015239/https://daily.jstor.org/how-does-the-body-make-vitamin-d-from-sunlight/ |dead-url=no }}</ref><ref>{{cite journal | vauthors = Holick MF, MacLaughlin JA, Clark MB, Holick SA, Potts JT, Anderson RR, Blank IH, Parrish JA, Elias P | display-authors = 6 | title = Photosynthesis of previtamin D3 in human skin and the physiologic consequences | journal = Science | volume = 210 | issue = 4466 | pages = 203–5 | date = October 1980 | pmid = 6251551 | doi = 10.1126/science.6251551 | bibcode = 1980Sci...210..203H | jstor = 1685024 }}</ref>，而[[维生素D3|维生素D<sub>3</sub>]]需由[[紫外線|紫外線]]照射，7-脫氫膽固醇經光照後進行光化學反應轉變而成，動物皮膚細胞中含有7-脫氫膽固醇，因此多照日光是獲取维生素D的簡易方法，而人類只要一天暴露在陽光下10分鐘，人體自身即可合成足夠的维生素D<sub>3</sub><ref>{{Cite web|title=穿过窗户的阳光不能帮助人体产生维生素D|url=https://www.solidot.org/story?sid=59691|work=奇客|accessdate=2019-03-06|archive-date=2020-12-22|archive-url=https://web.archive.org/web/20201222015326/https://www.solidot.org/story?sid=59691|dead-url=no}}</ref>。由於人口中的日照量是可變的，而且考慮到[[皮膚癌|皮膚癌]]的風險，因此關於安全的日照量的建議尚不確定，[[参考膳食摄入量|推薦膳食攝取量]]通常會假設一個人的所有維生素D都是透過口腔攝取的<ref name=NIH2016/>。

膽鈣化醇和麥角鈣化醇可以從飲食和補充劑中攝取<ref name="Holick_2006"/><ref name="Calvo_2005">{{cite journal | vauthors = Calvo MS, Whiting SJ, Barton CN | title = Vitamin D intake: a global perspective of current status | url = https://archive.org/details/sim_journal-of-nutrition_2005-02_135_2/page/310 | journal = The Journal of Nutrition | volume = 135 | issue = 2 | pages = 310–6 | date = February 2005 | pmid = 15671233 | doi = 10.1093/jn/135.2.310 | doi-access = free }}</ref><ref name="Norman_2008">{{cite journal | vauthors = Norman AW | title = From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health | journal = The American Journal of Clinical Nutrition | volume = 88 | issue = 2 | pages = 491S–499S | date = August 2008 | pmid = 18689389 | doi = 10.1093/ajcn/88.2.491S | doi-access = free }}</ref>。只有少數食物，例如是富含脂肪的魚類，天然含有顯著大量的維生素D<ref name=NIH2016/><ref>{{cite journal | vauthors = Lehmann U, Gjessing HR, Hirche F, Mueller-Belecke A, Gudbrandsen OA, Ueland PM, Mellgren G, Lauritzen L, Lindqvist H, Hansen AL, Erkkilä AT, Pot GK, Stangl GI, Dierkes J | display-authors = 6 | title = Efficacy of fish intake on vitamin D status: a meta-analysis of randomized controlled trials | url = https://archive.org/details/sim_american-journal-of-clinical-nutrition_2015-10_102_4/page/837 | journal = The American Journal of Clinical Nutrition | volume = 102 | issue = 4 | pages = 837–47 | date = October 2015 | pmid = 26354531 | doi = 10.3945/ajcn.114.105395 | doi-access = free }}</ref>。在美國和其他國家或地區，牛奶和植物奶的替代品都富含維生素D，而許多早餐穀物也是如此。暴露於紫外線下的蘑菇能提供有用的維生素D<ref name=NIH2016/>。

飲食中或皮膚合成中的維他命D於生物學上缺乏活性，它需要透過兩種蛋白質酶[[羥基化|羥基化]]的步驟激活，首先在肝臟中進行，其後於腎臟中進行。由於大多數[[哺乳類動物|哺乳類動物]]若暴露於充足的陽光下可以合成足夠分量的維他命D，因此它並非必需的，所以從技術上講它不是一種[[維他命|維他命]]<ref name="Norman_2008"/>。相反，它可以被認為是一種激素，其中激活維他命D激素原，形成[[骨化三醇|骨化三醇]]的活性形式，然後透過[[核受體|核受體]]於多個位置產生作用<ref name="Norman_2008"/>。膽鈣化固醇在肝臟中轉化為{{le|骨化二醇|Calcifediol}}（25-羥基膽鈣化固醇）；[[麥角鈣化醇|麥角鈣化醇]]被轉化為25-羥基麥角鈣化固醇，然後物質作為一種[[激素|激素]]重新進入循環系統，調節[[鈣|鈣]]和[[磷|磷]]的吸收，促進骨骼的生長和重構。骨化二醇活性不高，必須經肝臟及腎臟的酶反應，最終生成[[骨化三醇|骨化三醇]]，這才是其活性最高的形式，可以調節小腸、腎臟和骨骼對鈣的吸收與代謝。

會進一步被腎臟羥化形成維他命D的生物活性形式──[[骨化三醇|骨化三醇]]（也稱為1,25-二羥基膽鈣化固醇）<ref name="autogenerated2799">{{cite journal | vauthors = Holick MF, Schnoes HK, DeLuca HF, Suda T, Cousins RJ | title = Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine | journal = Biochemistry | volume = 10 | issue = 14 | pages = 2799–804 | date = July 1971 | pmid = 4326883 | doi = 10.1021/bi00790a023 }}</ref>。骨化三醇在血液中作為激素循環，主要作用是調節[[鈣|鈣]]和[[磷酸鹽|磷酸鹽]]的濃度，並促進骨骼的健康生長和重塑。骨化三醇還具有其他作用，包括對細胞生長、神經肌肉和免疫功能以及減輕炎症的作用<ref name=NIH2016>{{cite web |title=Vitamin D Fact Sheet for Health Professionals |url=https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/ |publisher=National Institutes of Health (NIH) |access-date=2017-06-06 |date=2016-02-11 |archive-date=2016-12-31 |archive-url=https://web.archive.org/web/20161231073744/https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/ |dead-url=yes }}{{PD-notice}}</ref>。

在[[血清|血清]]中測量兩種維他命D代謝物（稱為25-羥基維生素D或25(OH)D）的含量，以確定一個人的維他命D狀況<ref>{{cite web |title=Vitamin D Tests |url=http://labtestsonline.org/understanding/analytes/vitamin-d/tab/sample |work=Lab Tests Online (USA) |publisher=American Association for Clinical Chemistry |access-date=2013-06-23 |archive-date=2017-11-07 |archive-url=https://web.archive.org/web/20171107113730/https://labtestsonline.org/understanding/analytes/vitamin-d/tab/sample |dead-url=no }}</ref><ref name="Hollis_1996">{{cite journal | vauthors = Hollis BW | s2cid = 35887181 | title = Assessment of vitamin D nutritional and hormonal status: what to measure and how to do it | journal = Calcified Tissue International | volume = 58 | issue = 1 | pages = 4–5 | date = January 1996 | pmid = 8825231 | doi = 10.1007/BF02509538 }}</ref>。{{le|骨化二醇#血液测试|Calcifediol#Blood test|檢測血漿中的維他命D<sub>3</sub>}}可以反映[[紫外線#科學上的分類|UVB]]照射皮膚合成與食物攝入的維他命D的總水平，現時主要認為人體內獲取維他命D的主要途徑是由人體自身合成。維他命D對人體有益的最佳證據是對骨骼有益處並減少老年女性的死亡率，然而在一般人口統計中並沒有一致的證據顯示維他命D對健康有影響的效果。

維他命D的發現是由於努力尋找[[佝僂病|佝僂病]]兒童（兒童時期的{{le|軟骨症|Osteomalacia}}）所缺乏的飲食物質（維他命D<sub>3</sub>）<ref name="Wolf_2004">{{cite journal | vauthors = Wolf G | title = The discovery of vitamin D: the contribution of Adolf Windaus | url = https://archive.org/details/sim_journal-of-nutrition_2004-06_134_6/page/1299 | journal = The Journal of Nutrition | volume = 134 | issue = 6 | pages = 1299–302 | date = June 2004 | pmid = 15173387 | doi = 10.1093/jn/134.6.1299 | doi-access = free }}</ref>，此病症較常見於寒帶地區，由於當地居民須穿著厚重衣物以防寒，隔絕了陽光對皮膚的照射，因此無法自行生成維他命D<sub>3</sub>，只能經由飲食攝取來改善。維他命D補充劑可治療或預防軟骨症和佝僂病，然而在普遍人群中對補充維他命D的其他健康影響的證據不一致<ref name=Heart10>{{cite journal | vauthors = Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, Lichtenstein AH, Lau J, Balk EM | display-authors = 6 | title = Systematic review: Vitamin D and cardiometabolic outcomes | journal = Annals of Internal Medicine | volume = 152 | issue = 5 | pages = 307–14 | date = March 2010 | pmid = 20194237 | pmc = 3211092 | doi = 10.7326/0003-4819-152-5-201003020-00009 }}</ref><ref name="Balk09"/>。補充維他命D對死亡率的影響尚不清楚，一項綜合分析發現，老年人的死亡率略有下降<ref name=Bj2014/>，另一個建議服用補充劑以預防多種疾病的建議則沒有明確理由的結論，因此在這些領域中無需進行類似設計的進一步研究<ref name=Futil2014/>。若攝取過量的維他命D會導致中毒，使軟組織形成鈣化現象。
{{TOC limit|3}}

== 種類 ==
{| class="wikitable" style="width: 40%; float: right; font-size: 90%; margin-left: 25px;"
|-
! style="width: 80px;"|名稱
! 化學名稱
! 化學結構
|-
! 维生素D<sub>1</sub>
| [[麥角鈣化醇|麥角鈣化醇]]和[[光甾醇|光甾醇]]的比例為1：1的分子化合物
| style="text-align: center;" |
|-
! 维生素D<sub>2</sub>
| [[麥角鈣化醇|麥角鈣化醇]]（由[[麥角固醇|麥角固醇]]形成）
| style="text-align: center;"|[[File:Ergocalciferol.svg|70px]]位於頂部中心。]]
|-
! 维生素D<sub>3</sub>
|[[膽鈣化醇|膽鈣化醇]]（[[7-脫氫膽固醇|7-脫氫膽固醇]]於皮膚上形成）<br>[[骨化三醇|骨化三醇]]（维生素D<sub>3</sub>的在體內的活性形式 — 1,25-二羥膽鈣化醇）
| style="text-align: center;"|[[File:Cholecalciferol.svg|70px]]
|-
! 维生素D<sub>4</sub>
|{{le|22-二氫麥角鈣化醇|22-Dihydroergocalciferol}}
| style="text-align: center;"|[[File:22-Dihydroergocalciferol.png|70px]]
|-
! 维生素D<sub>5</sub>
| {{le|谷鈣化醇|22-Dihydroergocalciferol}}  （[[7-脫氫谷固醇|7-脫氫谷固醇]]形成）
| style="text-align: center;"|[[File:Vitamin_D5_structure.svg|80px]]
|}

維生素D有很多種不同的形式存在。兩種最主要的維生素D種類分別是維生素D<sub>2</sub>（[[麥角鈣化醇|麥角鈣化醇]]）和維生素D<sub>3</sub>（[[膽鈣化醇|膽鈣化醇]]），它們統稱為鈣化醇。1932年，研究人員闡明了維生素D<sub>2</sub>的結構，而人們於1936年發現了維生素D<sub>3</sub>，並發現它可以由7-脫氫膽固醇經紫外線照射轉化而成<ref>[http://vitamind.ucr.edu/history.html History of Vitamin D] {{Wayback|url=http://vitamind.ucr.edu/history.html |date=20111128033458 }} University of California, Riverside, Vitamin D Workshop.</ref>。沒有下標的是涵蓋所有維生素D，指D<sub>2</sub>或D<sub>3</sub>或是兩者，這些統稱為鈣化醇<ref>''Dorland's Illustrated Medical Dictionary'', under Vitamin (Table of Vitamins)</ref>。維生素D<sub>2</sub>的化學特徵是在1931年獲證明，維生素D<sub>3</sub>的化學結構於1935年建立，並證明是紫外線照射7-脫氫膽固醇而產生的<ref name="River">[http://vitamind.ucr.edu/about.html About Vitamin D] {{Wayback|url=http://vitamind.ucr.edu/about.html |date=20111115060853 }} Including Sections: History, Nutrition, Chemistry, Biochemistry, and Diseases. University of California Riverside</ref>。從化學結構上來說，維他命D都屬於開環甾體化合物，也就是甾體激素的一個環狀結構打開了<ref name="River"/>，維生素D<sub>2</sub>與維生素D<sub>3</sub>結構的不同之處在於其側鏈，維生素D<sub>2</sub>的22和23位碳之間是雙鍵，而且在24位碳上多了一個甲基；維生素D<sub>3</sub>（膽鈣化醇）可以由其前體7-脫氫膽固醇經過紫外線照射變構形成，只要讓皮膚暴露於充足的紫外光下即可以自然產生足夠維生素D<sub>3</sub>的分量，奶製品廠家通常把牛奶置於紫外線光下，以強化其中的維生素D<sub>3</sub>。

化學上，各種形式的維他命D都是{{le|開環甾體|secosteroid}}，即[[類固醇|類固醇]]，類固醇環的其中之一個鍵被破壞<ref name="River"/>。維他命D<sub>2</sub>和維他命D<sub>3</sub>之間的結構差異在於D<sub>2</sub>在碳22和23之間包含著一個[[側鏈|側鏈]]，以及在碳24上有一個[[甲基|甲基]]。

維他命D<sub>2</sub>是麥角固醇的衍生物，麥角固醇之所以以「麥角」命名，因為它是從一種名為[[麥角菌|麥角菌]]的[[真菌|真菌]]細胞膜上找到的固醇。麥角固醇同時也可以由浮游生物、無脊椎動物以及其他真菌合成。麥角固醇一經合成，在紫外線照射下就可以轉化為麥角鈣化醇，陸地動物和脊椎動物中的維他命D<sub>2</sub>，由於牠們體內不能合成麥角固醇，但能夠合成維他命D<sub>3</sub><ref name=holick2011>{{cite journal | author=Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM| title = Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline |journal = J Clin Endocrinol Metab| date = 2011-06-06| pmid = 21646368| doi=10.1210/jc.2011-0385 | volume=96 | issue=7 | pages=1911–30}}</ref>，但關於人類只服用維他命D<sub>2</sub>能否代替維他命D<sub>3</sub>攝入的討論，當中的爭論還是很激烈<ref name="pmid17023693">{{cite journal| author = Houghton LA, Vieth R| title = The case against ergocalciferol (vitamin D<sub>2</sub>) as a vitamin supplement| journal = [[The_American_Journal_of_Clinical_Nutrition|The American Journal of Clinical Nutrition]]| volume = 84| issue = 4| pages = 694–7| pmid = 17023693| url = http://www.ajcn.org/content/84/4/694.full.pdf| date = October 2006| access-date = 2012-01-02| archive-date = 2012-07-03| archive-url = https://web.archive.org/web/20120703210542/http://www.ajcn.org/content/84/4/694.full.pdf| dead-url = no}}</ref><ref name="Holick Biancuzzo Chen Klein 2008 pp. 677–681">{{cite journal | last=Holick | first=Michael F. | last2=Biancuzzo | first2=Rachael M. | last3=Chen | first3=Tai C. | last4=Klein | first4=Ellen K. | last5=Young | first5=Azzie | last6=Bibuld | first6=Douglass | last7=Reitz | first7=Richard | last8=Salameh | first8=Wael | last9=Ameri | first9=Allen | last10=Tannenbaum | first10=Andrew D. | title=Vitamin D2Is as Effective as Vitamin D3in Maintaining Circulating Concentrations of 25-Hydroxyvitamin D | journal=The Journal of Clinical Endocrinology & Metabolism | publisher=The Endocrine Society | volume=93 | issue=3 | year=2008 | issn=0021-972X | doi=10.1210/jc.2007-2308 | pages=677–681}}</ref>。

== 生物學 ==
活性維他命D代謝物骨化三醇透過跟主要位於靶細胞的[[細胞核|細胞核]]中的{{le|維他命D受體（VDR）|Vitamin D receptor}}結合來介導其生物學作用<ref name="River" />。骨化三醇與VDR的結合使VDR可以作為[[轉錄因子|轉錄因子]]來調節轉運蛋白的[[基因表達|基因表達]]（如{{le|TRPV6|TRPV6}}和[[鈣合蛋白|鈣合蛋白]]），它們參與腸道中鈣質的吸收<ref name=Bouillon2003>{{cite journal | vauthors = Bouillon R, Van Cromphaut S, Carmeliet G | title = Intestinal calcium absorption: Molecular vitamin D mediated mechanisms | journal = Journal of Cellular Biochemistry | volume = 88 | issue = 2 | pages = 332–9 | date = February 2003 | pmid = 12520535 | doi = 10.1002/jcb.10360 }}</ref>。維他命D受體屬於{{le|類固醇／甲狀腺激素受體|Steroid hormone receptor}}的[[核受體|核受體]]超級家族，以及VDR表現於大多數[[器官|器官]]的細胞中，包括[[腦|腦]]、[[心臟|心臟]]、[[皮膚|皮膚]]、[[生殖腺|生殖腺]]、[[前列腺|前列腺]]和[[乳房|乳房]]。

在小腸、骨骼、腎臟及甲狀旁腺細胞的VDR激活導致血液中鈣和磷的水平得以維持（在甲狀旁腺激素和[[降鈣素|降鈣素]]的輔助下），並維持了骨骼含量<ref name="Holick 2004">{{cite journal | vauthors = Holick MF | title = Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease | journal = The American Journal of Clinical Nutrition | volume = 80 | issue = 6 Suppl | pages = 1678S–88S | date = December 2004 | pmid = 15585788 | doi = 10.1093/ajcn/80.6.1678S | doi-access = free }}</ref>。

維他命D的最重要作用之一是透過促進腸道內的{{le|鈣代謝|Calcium metabolism}}以維持骨骼中鈣質的平衡，並通過增加[[破骨細胞|破骨細胞]]的數量和保持[[成骨作用|成骨作用]]中鈣和磷酸鹽水平以促進{{le|骨吸收|Bone resorption}}，並讓甲狀旁腺激素的正常運作以維持血清中鈣的水平。[[維生素D缺乏症|維他命D缺乏症]]會導致骨骼礦物質密度降低，並由於缺乏維他命D會改變人體中的礦物質代謝，導致骨密度降低（[[骨質疏鬆症|骨質疏鬆症]]）或[[骨折|骨折]]風險的增加<ref name="Bell">{{cite journal | vauthors = Bell TD, Demay MB, Burnett-Bowie SA | title = The biology and pathology of vitamin D control in bone | journal = Journal of Cellular Biochemistry | volume = 111 | issue = 1 | pages = 7–13 | date = September 2010 | pmid = 20506379 | pmc = 4020510 | doi = 10.1002/jcb.22661 }}</ref>。因此，維他命D通過作為骨吸收中有效刺激物的作用，這對{{le|骨骼重塑|Bone remodeling}}也至關重要<ref name=Bell/>。

VDR調節[[細胞增殖|細胞增殖]]和[[細胞分化|細胞分化]]。維他命D也影響免疫系統，而VDR在幾種[[白血球|白血球]]中表達，包括[[单核细胞|單核白血球]]和活化的[[T細胞|T細胞]]和[[B細胞|B細胞]]<ref name="PDR">{{cite journal | vauthors = Watkins RR, Lemonovich TL, Salata RA | title = An update on the association of vitamin D deficiency with common infectious diseases | journal = Canadian Journal of Physiology and Pharmacology | volume = 93 | issue = 5 | pages = 363–8 | date = May 2015 | pmid = 25741906 | doi = 10.1139/cjpp-2014-0352 }}</ref>。在體外，維他命D增加[[腎上腺|腎上腺]]{{le|髓質|Adrenal medulla}}細胞中[[酪氨酸羥化酶|酪氨酸羥化酶]]基因的表達，並影響了{{le|神經營養因子|Neurotrophic factors}}、[[一氧化氮合酶|一氧化氮合酶]]及[[谷胱甘肽|穀胱甘肽]]的合成<ref name="pmid9011759">{{cite journal | vauthors = Puchacz E, Stumpf WE, Stachowiak EK, Stachowiak MK | title = Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells | journal = Brain Research. Molecular Brain Research | volume = 36 | issue = 1 | pages = 193–6 | date = February 1996 | pmid = 9011759 | doi = 10.1016/0169-328X(95)00314-I }}</ref>。

維他命D受體的表達會隨年齡增長而降低，研究結果表明維他命D與肌肉力量、質量和功能直接相關，而所有這些都是影響運動員表現的重要因素<ref name=Angeline2013>{{cite journal | vauthors = Angeline ME, Gee AO, Shindle M, Warren RF, Rodeo SA | s2cid = 21395800 | title = The effects of vitamin D deficiency in athletes | url = https://archive.org/details/sim_american-journal-of-sports-medicine_2013-02_41_2/page/461 | journal = The American Journal of Sports Medicine | volume = 41 | issue = 2 | pages = 461–4 | date = February 2013 | pmid = 23371942 | doi = 10.1177/0363546513475787 }}</ref>。

== 膳食攝入 ==
=== 建議攝入量 ===
{| class="wikitable" style="float: right; font-size: 80%; text-align: center; margin-left: 1em"
|-
| colspan="3" style="background: blue; color: white; font-size: 110%; text-align: center;" | '''美國''' 
|-
! scope="col" width="100em" | 年齡組別
! scope="col" width="8em"| RDA (IU/日)
! scope="col" width="8em"| (μg/日)<ref name="Ross_2011"/>
|-
| 0–6個月嬰兒 || 400* || 10 
|-
| 6–12個月嬰兒 || 400* || 10 
|-
| 1–70歲 || 600 || 15 
|-
| 71+歲以上 || 800 || 20 
|-
| 懷孕／哺乳 || 600 || 15 
|-
! scope="col" | 年齡組別
! scope="col" | 容許攝入量上限（IU／日）
! scope="col" | (μg/日)
|-
| 0–6個月嬰兒 || 1,000 || 25
|-
| 6–12個月嬰兒 || 1,500 || 37.5
|-
| 1–3歲兒童 || 2,500 || 62.5
|-
| 4–8歲兒童 || 3,000 || 75
|-
| 9+歲 || 4,000 ||100
|-
| 懷孕／哺乳 || 4,000 ||100 <ref name="Ross_2011"/>
|-
| colspan="3" style="background: blue; color: white; font-size: 110%; text-align: center;"  | '''加拿大''' 
|-
! scope="col"  | 年齡組別
! scope="col"  | RDA (IU)
! scope="col"  | 容許攝入量上限（IU）<ref name="HCanada"/>
|-
| 0–6個月嬰兒 || 400* || 1,000
|-
| 6–12個月嬰兒 || 400* || 1,500
|-
| 1–3歲兒童 || 600 || 2,500
|-
| 4–8歲兒童 || 600 || 3,000
|-
| 9–70歲兒童及成人 || 600 || 4,000
|-
| 70歲以上成人 || 800 || 4,000
|-
| 懷孕／哺乳 || 600 || 4,000
|-
|colspan="3" style="background: blue; color: white; font-size: 110%; text-align: center;"  | '''澳洲及紐西蘭'''
|-
! scope="col" | 年齡組別
! scope="col" | 充足攝入量（μg）
! scope="col" | 最高攝入量（μg）<ref name="AusNZ"/>
|-
| 0–12個月嬰兒 || 5* || 25
|-
| 1–18歲兒童 || 5* || 80
|-
| 19–50歲成人 || 5* || 80
|-
| 51–70歲成人 || 10* || 80
|-
| 70歲以上成人 || 15* || 80
|-
|- 
|colspan="3" style="background: blue; color: white; font-size: 110%; text-align: center;"  | '''歐洲食品安全局'''
|-
! scope="col" | 年齡組別
! scope="col" | 充足攝入量（μg）<ref name="EFSA-vitD"/>
! scope="col" | 可容忍上限（μg）<ref name="EFSA-2012"/>
|-
| 0–12個月嬰兒 || 10 || 25
|-
| 1–10歲兒童 || 15 || 50
|-
| 11–17歲兒童 || 15 || 100
|-
| 成年人 || 15 || 100
|-
| 懷孕／哺乳 || 15 || 100
|-
|-
| colspan="3" style="text-align: center;" | * 充足攝入量，尚未建立RDA/RDI
|}

轉換：1μg = 40 [[國際單位|IU]]。

各種機構對維他命D的每日攝入量都提出了不同的建議。這些數據都根據精確的定義，因應不同的年齡、懷孕或哺乳期而有所不同，關於維他命D對皮膚的合成作出了程度的假設<ref name="Ross_2011"/><ref name="HCanada"/><ref name="AusNZ"/><ref name="EFSA-vitD"/>。

==== 美國 ====
由美國醫學研究所（IoM，2015年更名為美國國家醫學研究院）於2010年發布的維他命D膳食參考攝入量，取代了先前的建議，這些建議是根據攝入量表示的。提出建議的前提是，假設由於暴露在陽光下不足，個別人士皮膚不能合成維他命D。維他命D的參考攝入量指的是食物、飲料和補品中的總攝入量，並假設已滿足鈣的需求<ref name="Ross_2011"/>。[[参考膳食摄入量|參考膳食攝取量]]（UL）被定義為「幾乎對所有普通人來說的幾乎沒有健康不利影響風險的每天平均營養素的最高攝入量<ref name="Ross_2011"/>。」儘管人們認為參考膳食攝取量十分安全，但有關長期影響的信息並不完整，因此不建議長期攝入這些分量<ref name="Ross_2011"/>。

為了美國食品和膳食補充劑標籤的目的，每份的含量表示為每日數值的百分比（％DV）。維他命D標籤的目的，每日數值的100％為400 IU（10 μg），然而在2016年5月27日，該標準修訂為800 IU（20 μg），以使其與RDA達成一致<ref name="FedReg">{{Cite web|url=https://www.gpo.gov/fdsys/pkg/FR-2016-05-27/pdf/2016-11867.pdf|title=Federal Register May 27, 2016 Food Labeling: Revision of the Nutrition and Supplement Facts Labels. FR page 33982.|access-date=2019-08-20|archive-date=2016-08-08|archive-url=https://web.archive.org/web/20160808164651/https://www.gpo.gov/fdsys/pkg/FR-2016-05-27/pdf/2016-11867.pdf|dead-url=no}}{{PD-notice}}</ref><ref>{{cite web | title=Daily Value Reference of the Dietary Supplement Label Database (DSLD) | website=Dietary Supplement Label Database (DSLD) | url=https://www.dsld.nlm.nih.gov/dsld/dailyvalue.jsp | access-date=2020-05-16 | archive-date=2020-04-07 | archive-url=https://web.archive.org/web/20200407073956/https://dsld.nlm.nih.gov/dsld/dailyvalue.jsp | dead-url=no }}</ref>。對於每年食品銷售額超過1,000萬美元的食品製造商，必須在2020年1月1日之前遵守最新的標籤規定，而每年食品銷售額不足1,000萬美元的食品製造商，則必須於2021年1月1日之前達到更新的標籤法規<ref name="FDA nutrition label">{{cite web | title=FDA provides information about dual columns on Nutrition Facts label | website=U.S. [[Food_and_Drug_Administration|Food and Drug Administration]] (FDA) | date=2019-12-30 | url=https://www.fda.gov/news-events/fda-brief/fda-brief-fda-provides-additional-information-about-requirements-dual-column-labeling-serving-sizes | access-date=2020-05-16 | archive-date=2021-01-23 | archive-url=https://web.archive.org/web/20210123092945/https://www.fda.gov/news-events/fda-brief/fda-brief-fda-provides-additional-information-about-requirements-dual-column-labeling-serving-sizes | dead-url=no }} {{PD-notice}}</ref><ref name="FDAdelay">{{cite web | title=Changes to the Nutrition Facts Label | website=U.S. [[Food_and_Drug_Administration|Food and Drug Administration]] (FDA) | date=2016-05-27 | url=https://www.fda.gov/food/food-labeling-nutrition/changes-nutrition-facts-label | access-date=2020-05-16 | archive-date=2019-04-22 | archive-url=https://web.archive.org/web/20190422154242/https://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/LabelingNutrition/ucm385663.htm | dead-url=no }} {{PD-notice}}</ref><ref>{{cite web | title=Industry Resources on the Changes to the Nutrition Facts Label | website=U.S. [[Food_and_Drug_Administration|Food and Drug Administration]] (FDA) | date=2018-12-21 | url=https://www.fda.gov/food/food-labeling-nutrition/industry-resources-changes-nutrition-facts-label | access-date=2020-05-16 | archive-date=2020-12-25 | archive-url=https://web.archive.org/web/20201225063145/https://www.fda.gov/food/food-labeling-nutrition/industry-resources-changes-nutrition-facts-label | dead-url=no }} {{PD-notice}}</ref>。在2020年1月1日合規日期之後的前六個月中，FDA計劃與製造商合作以達到新的營養成分標籤要求，並且在此期間將不著重於針對這些要求的執法行動<ref name="FDA nutrition label" />。[[參考每日攝入量|參考每日攝入量]]的新與舊表中列出了每日成人數值量。

==== 加拿大 ====
根據美國醫學研究所的報告<ref name="Ross_2011"/>，[[加拿大衛生部|加拿大衛生部]]於2012年發布了建議膳食攝入量（RDA）及維他命D的攝入量上限<ref name="HCanada">{{cite web |url=http://www.hc-sc.gc.ca/fn-an/nutrition/vitamin/vita-d-eng.php |title=Vitamin D and Calcium: Updated Dietary Reference Intakes |work=Nutrition and Healthy Eating |publisher=Health Canada |access-date=2018-04-28 |date=2008-12-05 |archive-date=2017-06-14 |archive-url=https://web.archive.org/web/20170614125403/http://www.hc-sc.gc.ca/fn-an/nutrition/vitamin/vita-d-eng.php |dead-url=no }}</ref>。

==== 澳洲及紐西蘭 ====
澳洲及紐西蘭在2005年發布了營養參考值，當中包括了飲食中維他命D的攝入量指南<ref name="AusNZ">{{cite web |url=http://www.nhmrc.gov.au/_files_nhmrc/file/publications/synopses/n35.pdf |title=Nutrient reference values for Australia and New Zealand |access-date=2018-04-28 |date=2005-09-09 |work=National Health and Medical Research Council |archive-url=https://web.archive.org/web/20170121003340/https://www.nhmrc.gov.au/_files_nhmrc/file/publications/synopses/n35.pdf |archive-date=2017-01-21 |dead-url=yes }}</ref>。大約有三分之一的澳洲人缺乏維他命D<ref>{{cite web |vauthors=Salleh A |title=Vitamin D food fortification on the table |date=2012-06-12 |publisher=Australian Broadcasting Corporation |url=http://www.abc.net.au/science/articles/2012/06/12/3522708.htm |accessdate=2020-08-13 |archive-date=2020-12-22 |archive-url=https://web.archive.org/web/20201222015352/http://www.abc.net.au/science/articles/2012/06/12/3522708.htm |dead-url=no }}</ref>。

==== 歐盟 ====
[[歐洲食品安全局|歐洲食品安全局]]（EFSA）於2016年審視了目前的證據<ref name="EFSA-vitD">{{Cite journal |last1=EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) |title=Dietary reference values for vitamin D |journal=EFSA Journal |volume=14 |issue=10 |pages=e04547 |doi=10.2903/j.efsa.2016.4547 |date=2016-06-29|doi-access=free }}</ref>，發現血清25（OH）D濃度與與肌肉骨骼健康的結果有很大的差異。他們認為無法得出維他命D的平均需求量與人口參考維他命D的攝入量值，血清25（OH）D濃度為50 nmol / L是合適的目標值。對於所有1歲以上的人們，包括孕婦或哺乳期的婦女，他們設定的每日攝入量為每天15μg（600 IU）<ref name="EFSA-vitD"/>。

EFSA審查了2012年的安全攝入量<ref name="EFSA-2012">{{Cite journal |last1=EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) |title=Scientific Opinion on the Tolerable Upper Intake Level of vitamin D |journal=EFSA Journal |volume=10 |issue=7 |doi=10.2903/j.efsa.2012.2813 |year=2012 |type=Submitted manuscript  |pages = 2813|doi-access=free }}</ref>，成年人的容許上限為每天100μg（4,000 IU），這與IOM有類似的結論。

英國[[國民保健署|國民保健署]]建議6個月至5歲的嬰幼兒、懷孕或哺乳婦女，以及缺乏陽光的老年人應每天服用維他命補充劑，以確保攝入足夠的維他命D<ref>{{cite web |url=http://www.nhs.uk/Conditions/vitamins-minerals/Pages/Vitamin-D.aspx |title=Vitamins and minerals – Vitamin D |website=[[National_Health_Service_(England)|National Health Service]] |date=2015-02-18 |access-date=2016-07-21 |archive-date=2017-10-30 |archive-url=https://web.archive.org/web/20171030213854/https://www.nhs.uk/Conditions/vitamins-minerals/Pages/Vitamin-D.aspx |dead-url=no }}</ref>。2016年7月，英國公共衛生部建議每人都考慮在秋季和冬季每天服用10µg的維他命補充劑，因為該時期的日光不足以合成維他命D<ref>{{cite web |url=https://www.gov.uk/government/news/phe-publishes-new-advice-on-vitamin-d |title=PHE publishes new advice on vitamin D |publisher=Public Health England |date=2016-07-21 |access-date=2016-07-21 |archive-date=2021-01-03 |archive-url=https://web.archive.org/web/20210103142730/https://www.gov.uk/government/news/phe-publishes-new-advice-on-vitamin-d |dead-url=no }}</ref>。

瑞典國家食品管理局建議，對於75歲以下的成人和兒童，每天應攝入10μg（400 IU）的維他命D<sub>3</sub>，而75歲及以上的成年人應服用20μg（800 IU）的分量<ref>{{Cite web |url=https://www.livsmedelsverket.se/livsmedel-och-innehall/naringsamne/vitaminer-och-antioxidanter/d-vitamin |title=Vitamin D (translated) |publisher=[[Swedish_National_Food_Agency|Swedish National Food Agency]] |language=sv |access-date=2018-10-19 |archive-date=2020-10-26 |archive-url=https://web.archive.org/web/20201026192059/https://www.livsmedelsverket.se/livsmedel-och-innehall/naringsamne/vitaminer-och-antioxidanter/d-vitamin |dead-url=no }}</ref>。

歐洲的非政府組織提出了其建議：德國營養學會推薦20μg<ref>[//www.dge.de/modules.php?name=Content&pa=showpage&pid=4&page=12 ''Vitamin-D-Bedarf bei fehlender endogener Synthese''] Deutsche Gesellschaft für Ernährung, January 2012</ref>；歐洲更年期協會建議更年期婦女於70歲之前服用15μg（600 IU），以及從71歲開始服用20μg（800 IU）。對於某些維他命D含量很低或合併症的患者，該劑量應增加至100μg（4,000 IU）<ref name="pmid22100145">{{cite journal | vauthors = Pérez-López FR, Brincat M, Erel CT, Tremollieres F, Gambacciani M, Lambrinoudaki I, Moen MH, Schenck-Gustafsson K, Vujovic S, Rozenberg S, Rees M | display-authors = 6 | title = EMAS position statement: Vitamin D and postmenopausal health | journal = Maturitas | volume = 71 | issue = 1 | pages = 83–8 | date = January 2012 | pmid = 22100145 | doi = 10.1016/j.maturitas.2011.11.002 }}</ref>。

==== 其他 ====
* 隨着近幾十年對維他命D的認識不斷加深，其重要性和需求量也在不斷調整，例如：
** 美國兒科學會於2003年推薦兒童每日補充5μg的維他命D（200個國際單位），2008年改為每天10μg（400個國際單位）<ref>來自美國兒科學會官方報告。</ref>；
** 美國、澳洲等國的推薦量：50歲以下是400-1,000個國際單位；50歲以上是1,000-2,000個國際單位；
** 中國居民膳食指南（2013版）也將嬰幼兒推薦維他命D攝入量提高至10μg（400國際單位）<ref name="#1">《中国居民膳食营养素参考摄入量速查手册》（2013版）Chinese DRIs Handbook</ref>；而成人的推薦量一般比兒童更高一些；
** 中國營養學會編輯的中國居民膳食指南（2013版）則將補充的上限從前一版的800個國際單位提高至最新的2,000個國際單位<ref name="#1"/>。
* 妊娠期和哺乳期女性應適當增加攝入量，以維持正常的血液濃度，特別是在高緯度地區和預產期在春冬季節的孕婦。但需注意的是維他命D的攝入量不是越高越好。
* 在陽光下曬15分鐘，而且維持每星期幾天，能夠在一定程度上防止缺乏維他命D<ref>{{Cite web |url=https://observer.com/2017/10/3-ways-to-avoid-becoming-vitamin-d-deficient-this-winter/ |title=Doctor’s Orders: Don’t Become Vitamin D Deficient This Winter |accessdate=2020-06-23 |archive-date=2020-12-22 |archive-url=https://web.archive.org/web/20201222015409/https://observer.com/2017/10/3-ways-to-avoid-becoming-vitamin-d-deficient-this-winter/ |dead-url=no }}</ref>。
* 過量表現：長期臨床實踐表明，一次性地注射30萬個單位能夠保證其安全性，但60萬單位則有過量中毒的風險；而口服中毒風險有個體差異存在，目前現有的實驗數據表明持續補充維生素D每日4,000-10,000國際單位不超過2個月未觀察到中毒現象。但由於維生素D為脂溶性，還是應該避免長期過量服用。建議在新的理論支持出現以前，預備終身服用者，每天的預防保健補充量不超過2,000國際單位（治療劑量除外）。維生素D中毒的症狀是異常口渴，眼睛發炎，皮膚瘙癢，厭食、嗜睡、嘔吐、腹瀉、尿頻以及鈣於血管壁、肝臟、肺部、腎臟、胃中的異常沉澱，關節疼痛和瀰漫性骨質脫礦化。

=== 來源 ===
儘管維他命D在大多數食物中都不是天然存在的<ref name="Holick_2006"/><ref name="Norman_2008"/>，它通常將其作為食品強化添加到加工食物中。在某些國家／地區，主食都以維他命D來人工強化<ref name="IoM250">{{cite book |title=DRI, Dietary reference intakes: for calcium, phosphorus, magnesium, vitamin D, and fluoride |publisher=National Academy Press |location=Washington, D.C |year=1997 |pages=250 |isbn=978-0-309-06350-0 |url=http://www.nap.edu/openbook.php?isbn=0309063507&page=250 |doi=10.17226/5776 |pmid=23115811 |author1=Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes |access-date=2020-08-14 |archive-date=2015-04-02 |archive-url=https://web.archive.org/web/20150402201104/http://www.nap.edu/openbook.php?isbn=0309063507&page=250 |dead-url=no }}</ref>。

==== 天然來源 ====
{{Main|麥角鈣化醇}}
通常，維他命D<sub>2</sub>都是發現於[[真菌|真菌]]中，而維他命D<sub>3</sub>都在動物中發現<ref name="pmid1297827"/><ref name="keegan"/>。維他命D<sub>2</sub>是由許多真菌中發現的[[麥角固醇|麥角固醇]]在紫外線照射下產生的。蘑菇和[[地衣|地衣]]會隨著紫外線的照射而增加維他命D<sub>2</sub>的含量<ref name="pmid11693362"/><ref name=usda-mush-light>{{cite web |author=Haytowitz DB |title=Vitamin D in mushrooms |url=https://www.ars.usda.gov/ARSUserFiles/80400525/Articles/AICR09_Mushroom_VitD.pdf |publisher=Nutrient Data Laboratory, US Department of Agriculture |access-date=2018-04-16 |date=2009 |archive-date=2021-02-01 |archive-url=https://web.archive.org/web/20210201181749/https://www.ars.usda.gov/ARSUserFiles/80400525/Articles/AICR09_Mushroom_VitD.pdf |dead-url=no }}{{PD-notice}}</ref>。這個過程於工業紫外線燈的模擬下，維他命D<sub>2</sub>有更高的濃度<ref name="keegan">{{cite journal | vauthors = Keegan RJ, Lu Z, Bogusz JM, Williams JE, Holick MF | title = Photobiology of vitamin D in mushrooms and its bioavailability in humans | journal = Dermato-Endocrinology | volume = 5 | issue = 1 | pages = 165–76 | date = January 2013 | pmid = 24494050 | pmc = 3897585 | doi = 10.4161/derm.23321 }}</ref>。

[[美國農業部|美國農業部]]報告維他命D<sub>2</sub>和D<sub>3</sub>含量合計為一個值：
{| class="wikitable"
|+ 真菌來源
! scope="col" colspan="2" | 來源
! scope="col" | 每克（μg）
! scope="col" | 每克（IU）
|-
| rowspan="2" | ''C. 地衣'', [[葉狀體|葉狀體]], 乾的<ref name="pmid11693362">{{cite journal | vauthors = Wang T, Bengtsson G, Kärnefelt I, Björn LO | title = Provitamins and vitamins D₂and D₃in Cladina spp. over a latitudinal gradient: possible correlation with UV levels | journal = Journal of Photochemistry and Photobiology. B, Biology | volume = 62 | issue = 1–2 | pages = 118–22 | date = September 2001 | pmid = 11693362 | doi = 10.1016/S1011-1344(01)00160-9 | url = http://lup.lub.lu.se/record/133512 | type = Submitted manuscript | access-date = 2020-08-14 | archive-date = 2020-05-28 | archive-url = https://web.archive.org/web/20200528231009/https://lup.lub.lu.se/search/publication/133512 | dead-url = yes }}</ref>
! scope="row" | 維他命D<sub>3</sub>
| 0.67 {{en dash}} 2.04
| 27 {{en dash}} 82
|-
! scope="row" | 維他命D<sub>2</sub>
| 0.22 {{en dash}} 0.55
| 8.8 {{en dash}} 22
|-
! scope="col" colspan="4" | [[雙孢蘑菇|雙孢蘑菇]]（一般蘑菇）：D<sub>2</sub> + D<sub>3</sub>
|-
! scope="row" rowspan="2" | 波多貝羅（Portobello）
| 原始的
| 0.003
| 0.1
|-
| 暴露於紫外線下
| 0.112
| 4.46
|-
! scope="row" rowspan="2" | 克里米尼（Crimini）
| 原始的
| 0.001
| 0.03
|-
| 暴露於紫外線下
| 0.319
| 12.76
|}

{| class="wikitable"
|+ 動物來源<ref name="USDA">{{cite web |url=http://ndb.nal.usda.gov/ndb/foods |title=Search, National Nutrient Database for Standard Reference Release 27 |date=2014 |publisher=US Department of Agriculture, Agricultural Research Service |access-date=2015-06-12 |archive-date=2016-07-30 |archive-url=https://web.archive.org/web/20160730230325/https://ndb.nal.usda.gov/ndb/foods |dead-url=no }}{{PD-notice}}</ref>
! scope="col" | 來源
! scope="col" | 每克（IU）
! scope="col" | 不規則狀況
|-
| 煮熟的[[蛋|蛋]]黃
| 0.7
| 61克的蛋含有44{{nbsp}}IU
|-
| 已煮熟的紅燒牛肝
| 0.5
| 
|-
| [[魚肝油|魚肝油]]
| 100
| 每[[茶匙_(單位)|茶匙]]含450{{nbsp}}IU（4.5{{nbsp}}克）
|-
! scope="col" colspan="3" | 脂肪魚類
|-
| 已乾熱煮熟粉紅色的[[三文魚|三文魚]]
| 5.2
| 
|-
| 已乾熱煮熟的混合品種[[鯖魚|鯖魚]]
| 4.6
| 
|-
| 油浸罐裝[[鮪魚|吞拿魚]]
| 2.7
| 
|-
| 油浸[[沙丁魚罐頭|沙丁魚罐頭]]
| 1.9
| 
|}

==== 食品強化 ====
含有維他命D的加工食品強化包括了一些果汁和果汁飲品，[[代餐|代餐]]能量棒、[[大豆蛋白|大豆蛋白]]的飲料、某些奶酪和奶酪產品、麵粉製品、嬰兒[[配方奶粉|配方奶粉]]、許多早餐[[穀物片|穀物]]和[[乳|乳製品]]<ref>{{cite journal | vauthors = de Lourdes Samaniego-Vaesken M, Alonso-Aperte E, Varela-Moreiras G | title = Vitamin food fortification today | journal = Food & Nutrition Research | volume = 56 | pages = 5459 | year = 2012 | pmid = 22481896 | pmc = 3319130 | doi = 10.3402/fnr.v56i0.5459 }}</ref><ref name="spiro">{{cite journal | vauthors = Spiro A, Buttriss JL | title = Vitamin D: An overview of vitamin D status and intake in Europe | journal = Nutrition Bulletin | volume = 39 | issue = 4 | pages = 322–350 | date = December 2014 | pmid = 25635171 | pmc = 4288313 | doi = 10.1111/nbu.12108 }}</ref>。

2016年，[[美国食品药品监督管理局|美國食品藥品監督管理局]]（FDA）修改了牛奶強化食品添加劑的法規<ref>{{cite web |url=https://www.fda.gov/food/food-additives-petitions/vitamin-d-milk-and-milk-alternatives |title=Vitamin D for Milk and Milk Alternatives |date=2016-07-15 |publisher=[[Food_and_Drug_Administration|Food and Drug Administration]] (FDA) |access-date=2017-02-22 |archive-date=2020-12-22 |archive-url=https://web.archive.org/web/20201222015435/https://www.fda.gov/food/food-additives-petitions/vitamin-d-milk-and-milk-alternatives |dead-url=no }}{{PD-notice}}</ref>，規定每100克乳製品中的維他命D<sub>3</sub>含量不得超過42 IU（美國每[[夸脫|夸脫]]的400 IU）；每100克的[[植物奶|植物奶]]有84 IU的維他命D<sub>2</sub>（每夸脫800 IU）；而基於植物的[[酸奶|乳酪]]或在大豆飲料產品中，每100克含有89 IU（每夸脫800 IU）<ref name="fda16">{{cite web |url=https://www.federalregister.gov/documents/2016/07/18/2016-16738/food-additives-permitted-for-direct-addition-to-food-for-human-consumption-vitamin-d2 |title=Federal Register: Food Additives Permitted for Direct Addition to Food for Human Consumption; Vitamin D2 |publisher=Food and Drug Administration, US Department of Health and Human Services |date=2016-07-18 |access-date=2017-02-22 |archive-date=2020-12-22 |archive-url=https://web.archive.org/web/20201222015508/https://www.federalregister.gov/documents/2016/07/18/2016-16738/food-additives-permitted-for-direct-addition-to-food-for-human-consumption-vitamin-d2 |dead-url=no }}{{PD-notice}}</ref><ref>{{cite web |url=https://www.ecfr.gov/cgi-bin/text-idx?SID=6a3d5fc7d54cdaa0e9fd783b6063449d&mc=true&node=se21.3.172_1379&rgn=div8 |title=§172.379 Vitamin D2 |access-date=2019-07-16 |publisher=Electronic Code of Federal Regulations |archive-date=2020-12-22 |archive-url=https://web.archive.org/web/20201222015511/https://www.ecfr.gov/cgi-bin/text-idx?SID=6a3d5fc7d54cdaa0e9fd783b6063449d&mc=true&node=se21.3.172_1379&rgn=div8 |dead-url=no }}{{PD-notice}}</ref><ref>{{cite web |url=https://www.ecfr.gov/cgi-bin/text-idx?SID=6a3d5fc7d54cdaa0e9fd783b6063449d&mc=true&node=se21.3.172_1380&rgn=div8 |title=§172.380 Vitamin D3 |access-date=2019-07-16 |publisher=Electronic Code of Federal Regulations |archive-date=2020-12-22 |archive-url=https://web.archive.org/web/20201222015519/https://www.ecfr.gov/cgi-bin/text-idx?SID=6a3d5fc7d54cdaa0e9fd783b6063449d&mc=true&node=se21.3.172_1380&rgn=div8 |dead-url=no }}{{PD-notice}}</ref>。植物奶被定義為由大豆、杏仁、米以及其他可替代為乳汁的植物來源而製成的飲料<ref>{{Cite web|url=https://nutritionrefined.com/milk-alternatives/|title=Dairy Milk alternatives|last=|first=|date=2019-08-09|website=nutritionrefined|archive-url=https://web.archive.org/web/20201222015457/https://nutritionrefined.com/milk-alternatives/|archive-date=2020-12-22|access-date=|dead-url=no}}</ref><ref>{{Cite web|url=https://osoblanco.org/non-dairy-milk-best-alternatives-of-cow-milk/|title=Alternative to dairy milk|last=|first=|date=2020-01-16|website=osoblanco|archive-url=https://web.archive.org/web/20201222015535/https://osoblanco.org/non-dairy-milk-best-alternatives-of-cow-milk/|archive-date=2020-12-22|access-date=|dead-url=no}}</ref>。

雖然一些研究發現維他命D<sub>3</sub>可以更快地提高血液中25(OH)D的水平，並在體內保持更長的活躍時間<ref>{{Cite journal |title=Vitamin D<sub>2</sub> vs. vitamin D<sub>3</sub>: Are they one and the same? |year=2013 |journal=Nutrition Bulletin |volume=38 |issue=2 |pages=243–248 |author=Tripkovic L |doi=10.1111/nbu.12029}}</ref><ref>{{cite journal | vauthors = Alshahrani F, Aljohani N | title = Vitamin D: deficiency, sufficiency and toxicity | journal = Nutrients | volume = 5 | issue = 9 | pages = 3605–16 | date = September 2013 | pmid = 24067388 | pmc = 3798924 | doi = 10.3390/nu5093605 }}</ref>，然而其他研究則認為維他命D<sub>2</sub>的來源具有相同的生物利用度，以及如維他命D<sub>3</sub>般有效用於提高和維持25（OH）D<ref name="keegan"/><ref>{{cite journal | vauthors = Biancuzzo RM, Clarke N, Reitz RE, Travison TG, Holick MF | title = Serum concentrations of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in response to vitamin D2 and vitamin D3 supplementation | journal = The Journal of Clinical Endocrinology and Metabolism | volume = 98 | issue = 3 | pages = 973–9 | date = March 2013 | pmid = 23386645 | pmc = 3590486 | doi = 10.1210/jc.2012-2114 }}</ref><ref name="borel">{{cite journal | vauthors = Borel P, Caillaud D, Cano NJ | s2cid = 9818323 | title = Vitamin D bioavailability: state of the art | journal = Critical Reviews in Food Science and Nutrition | volume = 55 | issue = 9 | pages = 1193–205 | year = 2015 | pmid = 24915331 | doi = 10.1080/10408398.2012.688897 }}</ref>。

=== 食物準備 ===
典型的食物中的維他命D含量會因烹飪而減少。煮沸、油炸和烘烤食品可保留原始維他命D的69{{en dash}}89％<ref>{{cite journal | vauthors = Jakobsen J, Knuthsen P | title = Stability of vitamin D in foodstuffs during cooking | journal = Food Chemistry | volume = 148 | pages = 170–5 | date = April 2014 | pmid = 24262542 | doi = 10.1016/j.foodchem.2013.10.043 }}</ref>。

== 維他命D缺乏症 ==
{{Main|维生素D缺乏症}}
[[File:Calcium_regulation.png|thumb]] 
全世界估計有十億人處於維他命D不足或缺乏<ref name=Angeline2013/>。維他命D不足的飲食加上日照不足會導致缺乏維他命D。兒童嚴重缺乏維他命D會導致患上[[佝僂病|佝僂病]]，這是一種骨骼的軟化和弱化的疾病，是一種發達國家中罕見的疾病<ref>{{cite web |date=2012-03-08 |title=Rickets |publisher=[[National_Health_Service|National Health Service]] |url=http://www.nhs.uk/conditions/Rickets/Pages/Introduction.aspx |access-date=2012-07-09 |archive-date=2017-10-11 |archive-url=https://web.archive.org/web/20171011165432/http://www.nhs.uk/Conditions/Rickets/Pages/Introduction.aspx |dead-url=no }}</ref>。[[維生素D缺乏症|維生素D缺乏症]]發現於世界各地的老年人中，在兒童及成年人中仍然很常見<ref>{{cite journal | vauthors = Munns CF, Shaw N, Kiely M, Specker BL, Thacher TD, Ozono K, Michigami T, Tiosano D, Mughal MZ, Mäkitie O, Ramos-Abad L, Ward L, DiMeglio LA, Atapattu N, Cassinelli H, Braegger C, Pettifor JM, Seth A, Idris HW, Bhatia V, Fu J, Goldberg G, Sävendahl L, Khadgawat R, Pludowski P, Maddock J, Hyppönen E, Oduwole A, Frew E, Aguiar M, Tulchinsky T, Butler G, Högler W | display-authors = 6 | title = Global Consensus Recommendations on Prevention and Management of Nutritional Rickets | journal = The Journal of Clinical Endocrinology and Metabolism | volume = 101 | issue = 2 | pages = 394–415 | date = February 2016 | pmid = 26745253 | pmc = 4880117 | doi = 10.1210/jc.2015-2175 }}</ref><ref name="pmid12014847">{{cite journal | vauthors = Eriksen EF, Glerup H | s2cid = 22112344 | title = Vitamin D deficiency and aging: implications for general health and osteoporosis | journal = Biogerontology | volume = 3 | issue = 1–2 | pages = 73–7 | year = 2002 | pmid = 12014847 | doi = 10.1023/A:1015263514765 }}</ref><ref name="Holick_2007">{{cite journal | vauthors = Holick MF | title = Vitamin D deficiency | journal = The New England Journal of Medicine | volume = 357 | issue = 3 | pages = 266–81 | date = July 2007 | pmid = 17634462 | doi = 10.1056/NEJMra070553 }}</ref>。缺乏症會導致骨骼礦化受損和骨骼損傷，從而導致出現骨骼軟化疾病<ref name="Brown_2008">{{cite book |first1=Judith E. |last1=Brown |first2=Janet |last2=Isaacs |first3=Bea |last3=Krinke |first4=Ellen |last4=Lechtenberg |first5=Maureen |last5=Murtaugh | name-list-format = vanc |title=Nutrition Through the Life Cycle |url={{google books |plainurl=y |id=TeQZBQAAQBAJ}}|date=2013-06-28|publisher=Cengage Learning|isbn=978-1-285-82025-5}}</ref>，包括兒童的佝僂病和成人的[[軟骨病|軟骨病]]。避免日曬會導致血液中的{{le|骨化二醇|Calcifediol}}（25-羥基維他命D）含量低<ref name="pmid18234141">{{cite journal | vauthors = Schoenmakers I, Goldberg GR, Prentice A | title = Abundant sunshine and vitamin D deficiency | url = https://archive.org/details/sim_british-journal-of-nutrition_2008-06_99_6/page/1171 | journal = The British Journal of Nutrition | volume = 99 | issue = 6 | pages = 1171–3 | date = June 2008 | pmid = 18234141 | pmc = 2758994 | doi = 10.1017/S0007114508898662 }}</ref>。維他命D缺乏會導致飲食中腸道對鈣的吸收下降至15％<ref name="Holick 2004" />。當不缺乏時，一個人通常吸收60-80％<ref name="Holick 2004" />。

=== 皮膚色素沉著 ===
生活在溫帶氣候中的深色皮膚的人被指出具低維他命D水平，但這個含義並不明確<ref name="pmid28620422">{{cite journal | vauthors = Lowe NM, Bhojani I | title = Special considerations for vitamin D in the south Asian population in the UK | journal = Therapeutic Advances in Musculoskeletal Disease | volume = 9 | issue = 6 | pages = 137–144 | date = June 2017 | pmid = 28620422 | pmc = 5466148 | doi = 10.1177/1759720X17704430 }}</ref><ref name="pmid24267433">{{cite journal | vauthors = O'Connor MY, Thoreson CK, Ramsey NL, Ricks M, Sumner AE | title = The uncertain significance of low vitamin D levels in African descent populations: a review of the bone and cardiometabolic literature | journal = Progress in Cardiovascular Diseases | volume = 56 | issue = 3 | pages = 261–9 | year = 2013 | pmid = 24267433 | pmc = 3894250 | doi = 10.1016/j.pcad.2013.10.015 }}</ref><ref name="pmid22688752">{{cite journal | vauthors = Freedman BI, Register TC | s2cid = 29026212 | title = Effect of race and genetics on vitamin D metabolism, bone and vascular health | journal = Nature Reviews. Nephrology | volume = 8 | issue = 8 | pages = 459–66 | date = June 2012 | pmid = 22688752 | doi = 10.1038/nrneph.2012.112 }}</ref>。深色皮膚的人產生維他命D的效率較低，因為其皮膚裡的黑色素會阻礙維他命D的合成<ref name="pmid28467404">{{cite journal | vauthors = Khalid AT, Moore CG, Hall C, Olabopo F, Rozario NL, Holick MF, Greenspan SL, Rajakumar K | display-authors = 6 | title = Utility of sun-reactive skin typing and melanin index for discerning vitamin D deficiency | journal = Pediatric Research | volume = 82 | issue = 3 | pages = 444–451 | date = September 2017 | pmid = 28467404 | pmc = 5570640 | doi = 10.1038/pr.2017.114 }}</ref>。維生素D缺乏症常見於美國的西班牙裔和非裔美國人，其維他命D水平會於冬季中顯著下降<ref name=holick2011/>。這是由於他們皮膚裡的黑色素所導致，黑色素是天然的防曬霜<ref  name=holick2011/>。

=== 骨骼健康 ===
==== 佝僂病 ====
{{Main|佝僂病}}
一種兒童時期的疾病 — 佝僂病，好發於3—18個月大之間<ref name=Wagner2008>{{cite journal | vauthors = Wagner CL, Greer FR | title = Prevention of rickets and vitamin D deficiency in infants, children, and adolescents | journal = Pediatrics | volume = 122 | issue = 5 | pages = 1142–52 | date = November 2008 | pmid = 18977996 | doi = 10.1542/peds.2008-1862 | doi-access = free }}</ref>，其特點是其骨骼生長受到阻礙，變得柔軟和虛弱，隨著幼童開始學步時，變形的[[長骨|長骨]]會因其體重的作用下而變得彎曲。北美和其他西方國家相繼有病例指出，首見於母乳餵養的初生嬰兒，以及膚色較深的人<ref name=Wagner2008/>。佝僂症的特徵是弓腿<ref name="Brown_2008"/>——可能是因缺乏鈣或磷及缺乏維他命D引起的；如今，該病主要在非洲，亞洲或中東等低收入國家中發現<ref name="pmid17943890">{{cite journal | vauthors = Lerch C, Meissner T | title = Interventions for the prevention of nutritional rickets in term born children | journal = The Cochrane Database of Systematic Reviews | issue = 4 | pages = CD006164 | date = October 2007 | pmid = 17943890 | doi = 10.1002/14651858.CD006164.pub2 | editor1-last = Lerch | editor1-first = Christian }}</ref>許多患有遺傳疾病的人（如偽維他命D缺乏性佝僂病）<ref>{{cite journal | vauthors = Zargar AH, Mithal A, Wani AI, Laway BA, Masoodi SR, Bashir MI, Ganie MA | title = Pseudovitamin D deficiency rickets--a report from the Indian subcontinent | journal = Postgraduate Medical Journal | volume = 76 | issue = 896 | pages = 369–72 | date = June 2000 | pmid = 10824056 | pmc = 1741602 | doi = 10.1136/pmj.76.896.369 }}</ref>。

孕婦[[維生素D缺乏症|維他命D缺乏症]]可能會導致嬰兒於出生前就出現明顯的骨骼疾病以及出生後骨骼質量受損<ref name=Elidrissy2016>{{cite journal | vauthors = Elidrissy AT | s2cid = 14727399 | title = The Return of Congenital Rickets, Are We Missing Occult Cases? | journal = Calcified Tissue International | volume = 99 | issue = 3 | pages = 227–36 | date = September 2016 | pmid = 27245342 | doi = 10.1007/s00223-016-0146-2 | type = Review }}</ref><ref name=PatersonAyoub2016>{{cite journal | vauthors = Paterson CR, Ayoub D | title = Congenital rickets due to vitamin D deficiency in the mothers | journal = Clinical Nutrition | volume = 34 | issue = 5 | pages = 793–8 | date = October 2015 | pmid = 25552383 | doi = 10.1016/j.clnu.2014.12.006 | type = Review }}</ref>。營養性佝僂病（Nutritional rickets）存在於一年四季都有陽光的國家，例如尼日利亞，並且可在不缺乏維他命D症的情況下發生<ref>{{cite journal | vauthors = Oramasionwu GE, Thacher TD, Pam SD, Pettifor JM, Abrams SA | title = Adaptation of calcium absorption during treatment of nutritional rickets in Nigerian children | journal = The British Journal of Nutrition | volume = 100 | issue = 2 | pages = 387–92 | date = August 2008 | pmid = 18197991 | doi = 10.1017/S0007114507901233 | url = https://espace.library.uq.edu.au/view/UQ:c3b1fb5/UQc3b1fb5_OA.pdf }}</ref><ref>{{cite journal | vauthors = Fischer PR, Rahman A, Cimma JP, Kyaw-Myint TO, Kabir AR, Talukder K, Hassan N, Manaster BJ, Staab DB, Duxbury JM, Welch RM, Meisner CA, Haque S, Combs GF | display-authors = 6 | title = Nutritional rickets without vitamin D deficiency in Bangladesh | url = https://archive.org/details/sim_journal-of-tropical-pediatrics_1999-10_45_5/page/291 | journal = Journal of Tropical Pediatrics | volume = 45 | issue = 5 | pages = 291–3 | date = October 1999 | pmid = 10584471 | doi = 10.1093/tropej/45.5.291 | doi-access = free }}</ref>。

儘管現在[[英國|英國]]很少發生佝僂病和骨質疏鬆症，但卻大量發生在某些移民社區，其中骨質疏鬆症的患者包括了穿著西式服裝、在看似在充足的日光下進行戶外活動的婦女<ref name="Dunnigan_1997">{{cite journal | vauthors = Dunnigan MG, Henderson JB | title = An epidemiological model of privational rickets and osteomalacia | url = https://archive.org/details/sim_proceedings-of-the-nutrition-society_1997-11_56_3/page/939 | journal = The Proceedings of the Nutrition Society | volume = 56 | issue = 3 | pages = 939–56 | date = November 1997 | pmid = 9483661 | doi = 10.1079/PNS19970100 | doi-access = free }}</ref>。除非飲食偏離以高攝入量的肉類、魚類和蛋以及低攝入量的高提取物[[穀物|穀物]]為特徵的西方雜食動物習慣，膚色較黝黑和減少陽光照射不會產生此病<ref>{{cite journal | vauthors = Robertson I, Ford JA, McIntosh WB, Dunnigan MG | title = The role of cereals in the aetiology of nutritional rickets: the lesson of the Irish National Nutrition Survey 1943-8 | journal = The British Journal of Nutrition | volume = 45 | issue = 1 | pages = 17–22 | date = January 1981 | pmid = 6970590 | doi = 10.1079/BJN19810073 | doi-access = free }}</ref><ref>{{cite journal |vauthors=Clements MR |title=The problem of rickets in UK Asians |url=https://archive.org/details/sim_journal-of-human-nutrition-and-dietetics_1989-04_2_2/page/105 |journal=Journal of Human Nutrition and Dietetics |volume=2 |issue=2 |year=1989 |doi=10.1111/j.1365-277X.1989.tb00015.x |pages=105–116}}</ref><ref name="Pettifor_2004">{{cite journal | vauthors = Pettifor JM | title = Nutritional rickets: deficiency of vitamin D, calcium, or both? | journal = The American Journal of Clinical Nutrition | volume = 80 | issue = 6 Suppl | pages = 1725S–9S | date = December 2004 | pmid = 15585795 | doi = 10.1093/ajcn/80.6.1725S | doi-access = free }}</ref>。佝僂病的飲食風險因素包括禁止食用動物食品<ref name="Dunnigan_1997"/><ref name="Dunnigan_2005">{{cite journal | vauthors = Dunnigan MG, Henderson JB, Hole DJ, Barbara Mawer E, Berry JL | title = Meat consumption reduces the risk of nutritional rickets and osteomalacia | url = https://archive.org/details/sim_british-journal-of-nutrition_2005-12_94_6/page/983 | journal = The British Journal of Nutrition | volume = 94 | issue = 6 | pages = 983–91 | date = December 2005 | pmid = 16351777 | doi = 10.1079/BJN20051558 | doi-access = free }}</ref>。

在大多數國家中，維他命D缺乏症仍然是嬰兒的主要病因，因為母乳中的維他命D含量不足，且社會風氣和氣候條件使人們避免獲得足購的日曬。在陽光充足的國家，例如尼日利亞，南非和孟加拉國，發病於較年長學步的幼會和兒童中，它被歸因於飲食中鈣攝入量低，這是只能有限地使用乳製品並佐以穀物為基礎的飲食<ref name="Pettifor_2004"/>。

佝僂病曾是美國的主要公衛問題。在[[丹佛|丹佛]]，同一緯度的紫外線強度比海平面強20％<ref>{{cite web |url=https://science.education.nih.gov/supplements/webversions/CellBiology/activities/activity5_database4.html |title=Cell Biology and Cancer Curriculum Supplement |publisher=Office of Science Education |access-date=2010-08-24 |archive-url=https://web.archive.org/web/20100608033634/https://science.education.nih.gov/supplements/nih1/Cancer/activities/activity5_database4.htm |archive-date=2010-06-08 |dead-url=no }}{{PD-notice}}</ref>，在1920年代後期，近500名兒童中有近三分之二患有輕度的佝僂病<ref>{{cite journal | vauthors = Weick MT | title = A history of rickets in the United States | url = https://archive.org/details/sim_american-journal-of-clinical-nutrition_1967-11_20_11/page/1234 | journal = The American Journal of Clinical Nutrition | volume = 20 | issue = 11 | pages = 1234–41 | date = November 1967 | pmid = 4862158 | doi = 10.1093/ajcn/20.11.1234 }}</ref>。20世紀美國飲食中的動物性蛋白比例增加<ref name="Dunnigan_2005"/><ref>{{cite book |vauthors=Garrison RH, Somer E |title=The Nutrition Desk Reference |url={{google books |plainurl=y |id=Z4hFKXI7EhsC}} |year=1997 |publisher=McGraw-Hill |isbn=978-0-87983-826-3}}</ref>加上牛奶的消耗量增加<ref name="Dupuis2002">{{cite book |first=E. Melanie |last=Dupuis |title=Nature's Perfect Food: How Milk Became America's Drink |url={{google books |plainurl=y |id=Nr1_u2DvDckC}}|date=2002-02-01|publisher=NYU Press|isbn=978-0-8147-1938-1 | name-list-format = vanc}}</ref><ref>{{cite journal | vauthors = Teegarden D, Lyle RM, Proulx WR, Johnston CC, Weaver CM | title = Previous milk consumption is associated with greater bone density in young women | url = https://archive.org/details/sim_american-journal-of-clinical-nutrition_1999-05_69_5/page/1014 | journal = The American Journal of Clinical Nutrition | volume = 69 | issue = 5 | pages = 1014–7 | date = May 1999 | pmid = 10232644 | doi = 10.1093/ajcn/69.5.1014 | doi-access = free }}</ref>，強化相對維他命D含量較少的情況下，佝僂病病例的數字急劇下降<ref name="Holick 2004" />。同樣，在美國和加拿大，維他命D強化牛奶、嬰兒補充劑和維他命補充劑已消除大多數佝僂病兒童所患有的脂肪吸收不良<ref name="Brown_2008"/>。

==== 骨質疏鬆症和骨軟化病 ====
{{Main|骨質疏鬆症|[[軟骨病|軟骨病]]}}
[[骨質疏鬆症|骨質疏鬆症]]是成年人的維他命D缺乏引起的疾病。該疾病的特徵是使骨骼軟化，導致脊柱彎曲、腿部彎曲、{{le|近端|Anatomical terms of location#Proximal and distal}}肌肉無力、骨骼脆弱，增加骨折風險<ref name="Insel_2006"/>。骨質疏鬆症減少了鈣質的吸收並增加了骨骼中鈣質的流失，那增加了骨折的風險。骨質疏鬆症通常出現於25-羥基維他命D水平低於約10ng/mL時<ref name="Holick_2006"/>。儘管人們認為軟骨病的影響可導致慢性[[肌肉骨骼系統|肌肉骨骼系統]][[疼痛|疼痛]]<ref>{{cite journal | vauthors = Holick MF | title = Vitamin D: A millenium perspective | journal = Journal of Cellular Biochemistry | volume = 88 | issue = 2 | pages = 296–307 | date = February 2003 | pmid = 12520530 | doi = 10.1002/jcb.10338 }}</ref>，這裡沒有具說服力的證據指出慢性疼痛患者出現較低的維他命D水平<ref>{{cite journal | vauthors = Straube S, Andrew Moore R, Derry S, McQuay HJ | s2cid = 17244398 | title = Vitamin D and chronic pain | journal = Pain | volume = 141 | issue = 1–2 | pages = 10–3 | date = January 2009 | pmid = 19084336 | doi = 10.1016/j.pain.2008.11.010 }}</ref>，或該補充劑可減輕慢性非特異性肌肉骨骼疼痛<ref>{{cite journal | vauthors = Gaikwad M, Vanlint S, Mittinity M, Moseley GL, Stocks N | s2cid = 30189971 | title = Does vitamin D supplementation alleviate chronic nonspecific musculoskeletal pain? A systematic review and meta-analysis | journal = Clinical Rheumatology | volume = 36 | issue = 5 | pages = 1201–1208 | date = May 2017 | pmid = 26861032 | doi = 10.1007/s10067-016-3205-1 | url = https://www.researchgate.net/publication/293637550 }}</ref>。

== 補充劑的使用 ==
維他命D補充劑是預防或治療[[佝僂病|佝僂病]]的一個可靠方法，然而它對非骨骼健康的影響尚未確定<ref name=Balk09>{{cite journal | vauthors = Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J, Lichtenstein A, Patel K, Raman G, Tatsioni A, Terasawa T, Trikalinos TA | display-authors = 6 | title = Vitamin D and calcium: a systematic review of health outcomes | journal = Evidence Report/Technology Assessment | issue = 183 | pages = 1–420 | date = August 2009 | pmid = 20629479 | pmc = 4781105 }}</ref><ref>{{cite journal | vauthors = Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP | title = Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials | journal = BMJ | volume = 348 | pages = g2035 | date = April 2014 | pmid = 24690624 | pmc = 3972415 | doi = 10.1136/bmj.g2035 }}</ref>。2013年的一項評論發現，除了可以降低老年人的死亡率外，並沒有發現補充劑對非骨骼疾病發生率有任何影響<ref name=Aut2013>{{cite journal | vauthors = Autier P, Boniol M, Pizot C, Mullie P | title = Vitamin D status and ill health: a systematic review | journal = The Lancet. Diabetes & Endocrinology | volume = 2 | issue = 1 | pages = 76–89 | date = January 2014 | pmid = 24622671 | doi = 10.1016/S2213-8587(13)70165-7 }}</ref>。維他命D補充劑不會改變[[心肌梗塞|心肌梗塞]]、[[中風|中風]]或[[腦血管疾病|腦血管疾病]]、癌症、膝蓋[[骨關節炎|骨關節炎]]的結果<ref name=Futil2014 /><ref name="Hussain_2017">{{cite journal | vauthors = Hussain S, Singh A, Akhtar M, Najmi AK | s2cid = 23994681 | title = Vitamin D supplementation for the management of knee osteoarthritis: a systematic review of randomized controlled trials | journal = Rheumatology International | volume = 37 | issue = 9 | pages = 1489–1498 | date = September 2017 | pmid = 28421358 | doi = 10.1007/s00296-017-3719-0 }}</ref>。維他命D水平可能是疾病引起，而非引致疾病的發生<ref name=Aut2013/>。美國{{le|醫學研究院|National Academy of Medicine}}（IOM）的一份報告指出：「跟[[癌症|癌症]]、[[心血管疾病|心血管疾病]]及[[高血壓|高血壓]]，以及[[糖尿病|糖尿病]]與代謝綜合症相關的結果，跌倒和身體機能、免疫功能和[[自體免疫性疾病|自體免疫性疾病]]、感染、神經心理機能及[[妊娠毒血症|子癇前症]]都不能與鈣質或維他命D攝入可靠地聯繫在一起，並且經常出現相互矛盾<ref name="Ross_2011"/>。」一些研究人員聲稱，IOM的建議過於明確，在計算與骨骼健康相關的維他命D水平時犯了數學上的錯誤<ref name=Maxmen2011/>。IOM小組成員堅持認為他們使用了「飲食建議的標準程序」，並且該報告是完全基於這些數據。維他命D補充劑的研究，包括了大規模的臨床試驗，繼續正在進行中<ref name=Maxmen2011>{{cite journal | vauthors = Maxmen A | title = Nutrition advice: the vitamin D-lemma | journal = Nature | volume = 475 | issue = 7354 | pages = 23–5 | date = July 2011 | pmid = 21734684 | doi = 10.1038/475023a | url = http://www.nature.com/news/2011/110706/pdf/475023a.pdf | doi-access = free | access-date = 2012-01-02 | archive-date = 2020-08-03 | archive-url = https://web.archive.org/web/20200803081923/https://www.nature.com/news/2011/110706/pdf/475023a.pdf | dead-url = no }}</ref>。

=== 骨骼健康 ===
在一般情況下，人們普遍認為維他命D補充劑有助預防骨質疏鬆症的觀點並沒有很好的證據支持<ref name=Futil2014/>。它通常用於預防這種疾病，因此那些沒有維他命D缺乏症的人可能沒有需要<ref>{{cite journal | vauthors = Reid IR, Bolland MJ, Grey A | title = Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis | journal = Lancet | volume = 383 | issue = 9912 | pages = 146–55 | date = January 2014 | pmid = 24119980 | doi = 10.1016/s0140-6736(13)61647-5 }}</ref>。對於患有骨質疏鬆症的老年人，把維他命D跟鈣質一同服用可能有助於預防髖部骨折，但它也會輕微增加了患上胃部及腎臟疾病的風險<ref>{{cite journal | vauthors = Avenell A, Mak JC, O'Connell D | title = Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men | journal = The Cochrane Database of Systematic Reviews | volume = 4 | issue = 4 | pages = CD000227 | date = April 2014 | pmid = 24729336 | pmc = 7032685 | doi = 10.1002/14651858.CD000227.pub4 }}</ref>。在65歲以上的人裡，調高劑量的維他命D補充劑可以降低骨折風險<ref name="pmid22762317">{{cite journal | vauthors = Bischoff-Ferrari HA, Willett WC, Orav EJ, Oray EJ, Lips P, Meunier PJ, Lyons RA, Flicker L, Wark J, Jackson RD, Cauley JA, Meyer HE, Pfeifer M, Sanders KM, Stähelin HB, Theiler R, Dawson-Hughes B | s2cid = 24338997 | display-authors = 6 | title = A pooled analysis of vitamin D dose requirements for fracture prevention | journal = The New England Journal of Medicine | volume = 367 | issue = 1 | pages = 40–9 | date = July 2012 | pmid = 22762317 | doi = 10.1056/NEJMoa1109617 | url = https://research.vu.nl/ws/files/709966/300335.pdf | hdl = 1871/48765 | access-date = 2020-08-16 | archive-date = 2020-12-15 | archive-url = https://web.archive.org/web/20201215140446/https://research.vu.nl/ws/files/709966/300335.pdf | dead-url = no }}</ref>。對於獨立生活的人而言，其影響是很小甚至是沒有的<ref name="ReferenceA">{{cite journal | vauthors = Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA | title = Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force | journal = Annals of Internal Medicine | volume = 155 | issue = 12 | pages = 827–38 | date = December 2011 | pmid = 22184690 | doi = 10.7326/0003-4819-155-12-201112200-00005 | doi-access = free }}</ref><ref>{{cite journal | vauthors = Zhao JG, Zeng XT, Wang J, Liu L | title = Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults: A Systematic Review and Meta-analysis | journal = JAMA | volume = 318 | issue = 24 | pages = 2466–2482 | date = December 2017 | pmid = 29279934 | pmc = 5820727 | doi = 10.1001/jama.2017.19344 }}</ref>。低血清維他命D水平跟[[跌倒|跌倒]]與低{{le|骨質密度|Bone density}}有關<ref name=Bone07>{{cite journal | vauthors = Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V | display-authors = 6 | title = Effectiveness and safety of vitamin D in relation to bone health | journal = Evidence Report/Technology Assessment | issue = 158 | pages = 1–235 | date = August 2007 | pmid = 18088161 | pmc = 4781354 }}</ref>。然而，服用額外的維他命D似乎並沒有改變風險<ref name="pmid24768505">{{cite journal | vauthors = Bolland MJ, Grey A, Gamble GD, Reid IR | title = Vitamin D supplementation and falls: a trial sequential meta-analysis | journal = The Lancet. Diabetes & Endocrinology | volume = 2 | issue = 7 | pages = 573–80 | date = July 2014 | pmid = 24768505 | doi = 10.1016/S2213-8587(14)70068-3 }}</ref>。維他命D缺乏症的運動員，特別是那些從事接觸運動的人，他們會增加患上[[疲勞性骨折|疲勞性骨折]]及/或嚴重骨折的風險。補充劑最大的好處可見於25（OH）D血清水平不足（<30{{nbsp}}ng/mL），或25（OH）D血清水平嚴重不足（<25{{nbsp}}ng/mL）的人身上。血清25（OH）D濃度升高穩定在50 ng/mL時，可觀察到風險增加，而在超過這一點的水平上，沒有其他可見的額外好處<ref>{{cite journal | vauthors = Shuler FD, Wingate MK, Moore GH, Giangarra C | title = Sports health benefits of vitamin d | journal = Sports Health | volume = 4 | issue = 6 | pages = 496–501 | date = November 2012 | pmid = 24179588 | pmc = 3497950 | doi = 10.1177/1941738112461621 }}</ref>。

由於發現了越來越多的有益於骨骼健康的證據，儘管它沒有找到其他益處的充分證據，[[美國食品藥品監督管理局|美國食品藥品監督管理局]]（FDA）自2016年5月起要求製造商於[[營養標籤|營養標籤]]上聲明維他命D的含量，以作為「具有公共衛生意義的營養素」。每年食品銷售額少於$1,000萬美元的小型製造商透過提議的截止日期延長，將必須在2021年1月1日之前遵守法規，而較大的則必須在2020年1月1日之前遵守<ref name="FDAdelay" />。單一成分糖（例如蜜糖和楓糖漿）及某些蔓越莓產品的製造商必須在2021年7月1日之前作出更改<ref name="FDAdelay" />。

=== 癌症 ===
維他命D補充劑因其聲稱的抗癌特性而被廣泛銷售<ref name=abc>{{cite journal | vauthors = Byers T | title = Anticancer vitamins du Jour--The ABCED's so far | journal = American Journal of Epidemiology | volume = 172 | issue = 1 | pages = 1–3 | date = July 2010 | pmid = 20562190 | pmc = 2892535 | doi = 10.1093/aje/kwq112 | type = Review }}</ref>。在觀察性研究中，維他命D水平低與某些癌症的發生風險之間存在著關聯<ref>{{cite journal | vauthors = Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ | s2cid = 24164628 | title = The role of vitamin D in reducing cancer risk and progression | journal = Nature Reviews. Cancer | volume = 14 | issue = 5 | pages = 342–57 | date = May 2014 | pmid = 24705652 | doi = 10.1038/nrc3691 }}</ref>。然而，尚未清楚在飲食中或作為維他命D補充劑是否會影響[[癌症|癌症]]的風險。評論把證據描述為「因果關係不一致，不確定，並且不足以告知營養需求」<ref name="Ross_2011"/>，和「不足以得出結論」<ref name="ReferenceA"/>。2014年的一篇評論發現補充劑對癌症風險沒有顯著影響<ref name=Futil2014/>。

2014年的另一篇評論得出結論，維他命D<sub>3</sub>可以降低癌症的死亡風險（在5年內接受治療的150人中，死亡人數減少了1人），但注意到對數據質量的擔憂<ref name=Bj2014 />。儘管有證據表明維他命D缺乏症對某些癌症結果更糟<ref name="Buttigliero">{{cite journal | vauthors = Buttigliero C, Monagheddu C, Petroni P, Saini A, Dogliotti L, Ciccone G, Berruti A | title = Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review | journal = The Oncologist | volume = 16 | issue = 9 | pages = 1215–27 | year = 2011 | pmid = 21835895 | pmc = 3228169 | doi = 10.1634/theoncologist.2011-0098 }}</ref>，在診斷時有較高的25-羥基維他命D水平與更好的結果有關<ref>{{cite journal | vauthors = Li M, Chen P, Li J, Chu R, Xie D, Wang H | title = Review: the impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis | journal = The Journal of Clinical Endocrinology and Metabolism | volume = 99 | issue = 7 | pages = 2327–36 | date = July 2014 | pmid = 24780061 | doi = 10.1210/jc.2013-4320 | doi-access = free }}</ref>。

=== 心血管疾病 ===
服用維他命D補充劑並不能有效降低[[中風|中風]]、[[腦血管疾病|腦血管疾病]]、[[心肌梗塞|心肌梗塞]]或[[冠狀動脈疾病|冠狀動脈疾病]]的風險<ref name=Futil2014>{{cite journal | vauthors = Bolland MJ, Grey A, Gamble GD, Reid IR | title = The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis | journal = The Lancet. Diabetes & Endocrinology | volume = 2 | issue = 4 | pages = 307–20 | date = April 2014 | pmid = 24703049 | doi = 10.1016/S2213-8587(13)70212-2 | type = Meta-analysis }}</ref><ref>{{cite journal | vauthors = Barbarawi M, Kheiri B, Zayed Y, Barbarawi O, Dhillon H, Swaid B, Yelangi A, Sundus S, Bachuwa G, Alkotob ML, Manson JE | display-authors = 6 | title = Vitamin D Supplementation and Cardiovascular Disease Risks in More Than 83 000 Individuals in 21 Randomized Clinical Trials: A Meta-analysis | journal = JAMA Cardiology | volume = 4 | issue = 8 | pages = 765–776 | date = August 2019 | pmid = 31215980 | pmc = 6584896 | doi = 10.1001/jamacardio.2019.1870 }}</ref>。補充劑可能對[[血壓|血壓]]並沒有影響<ref>{{cite journal | vauthors = Beveridge LA, Struthers AD, Khan F, Jorde R, Scragg R, Macdonald HM, Alvarez JA, Boxer RS, Dalbeni A, Gepner AD, Isbel NM, Larsen T, Nagpal J, Petchey WG, Stricker H, Strobel F, Tangpricha V, Toxqui L, Vaquero MP, Wamberg L, Zittermann A, Witham MD | display-authors = 6 | title = Effect of Vitamin D Supplementation on Blood Pressure: A Systematic Review and Meta-analysis Incorporating Individual Patient Data | journal = JAMA Internal Medicine | volume = 175 | issue = 5 | pages = 745–54 | date = May 2015 | pmid = 25775274 | pmc = 5966296 | doi = 10.1001/jamainternmed.2015.0237 }}</ref>。

=== 免疫系統 ===
==== 自身免疫性疾病 ====
儘管有初步數據表明哮喘跟維他命D水平低有關，但支持補充劑對哮喘患者具有益作用的證據則沒有證據支持<ref name="pmid22742645">{{cite journal | vauthors = Hart PH | title = Vitamin D supplementation, moderate sun exposure, and control of immune diseases | journal = Discovery Medicine | volume = 13 | issue = 73 | pages = 397–404 | date = June 2012 | pmid = 22742645 | doi =  | url = http://www.discoverymedicine.com/Prue-H-Hart/2012/06/14/vitamin-d-supplementation-moderate-sun-exposure-and-control-of-immune-diseases/ | access-date = 2020-08-17 | archive-date = 2020-08-12 | archive-url = https://web.archive.org/web/20200812212626/https://www.discoverymedicine.com/Prue-H-Hart/2012/06/14/vitamin-d-supplementation-moderate-sun-exposure-and-control-of-immune-diseases/ | dead-url = no }}</ref>。一項評論發現，維他命D補充劑可以減少用於抑制輕度至中度哮喘發作頻率類固醇的需要，並且這種補充對日常哮喘症狀沒有影響<ref>{{cite journal | vauthors = Martineau AR, Cates CJ, Urashima M, Jensen M, Griffiths AP, Nurmatov U, Sheikh A, Griffiths CJ | display-authors = 6 | title = Vitamin D for the management of asthma | journal = The Cochrane Database of Systematic Reviews | volume = 9 | pages = CD011511 | date = September 2016 | pmid = 27595415 | pmc = 6457769 | doi = 10.1002/14651858.cd011511.pub2 }}</ref>。在一般情況下，維他命D補充劑是並不建議用於治療或預防哮喘<ref>{{cite journal | vauthors = Paul G, Brehm JM, Alcorn JF, Holguín F, Aujla SJ, Celedón JC | title = Vitamin D and asthma | journal = American Journal of Respiratory and Critical Care Medicine | volume = 185 | issue = 2 | pages = 124–32 | date = January 2012 | pmid = 22016447 | pmc = 3297088 | doi = 10.1164/rccm.201108-1502CI }}</ref>。

==== 發炎性腸病 ====
維他命D含量低與兩種人類[[炎症性腸病|炎症性腸病]]（IBD）的主要形式有關：[[克隆氏症|克隆氏症]]及[[潰瘍性結腸炎|潰瘍性結腸炎]]<ref name="IBD2015">{{cite journal | vauthors = Del Pinto R, Pietropaoli D, Chandar AK, Ferri C, Cominelli F | title = Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis | journal = Inflammatory Bowel Diseases | volume = 21 | issue = 11 | pages = 2708–17 | date = November 2015 | pmid = 26348447 | pmc = 4615394 | doi = 10.1097/MIB.0000000000000546 }}</ref>。對於患有維他命D缺乏症的IBD患者進行維他命D治療的綜合分析顯示，補充劑可有效糾正維他命D水平，並與臨床疾病活動及生化標誌物指標的改進有關<ref>{{cite journal | vauthors = Guzman-Prado Y, Samson O, Segal JP, Limdi JK, Hayee B | title = Vitamin D Therapy in Adults With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis | journal = Inflammatory Bowel Diseases | date = May 2020 | pmid = 32385487 | doi = 10.1093/ibd/izaa087 }}</ref>。

==== 傳染病與COVID-19 ====
通常，維他命D的功能是激活[[先天免疫系統|先天免疫系統]]和抑制[[後天免疫系統|後天免疫系統]]<ref name="pmid21419266">{{Cite book |vauthors=Hewison M |chapter=Vitamin D and innate and adaptive immunity |volume=86 |pages=23–62 |year=2011 |pmid=21419266 |doi=10.1016/B978-0-12-386960-9.00002-2 |isbn=9780123869609 |series=Vitamins & Hormones|title=Vitamins and the Immune System }}</ref>。缺乏症跟[[病毒性疾病|病毒性疾病]]的風險或嚴重性增加有關，包括[[人類免疫缺陷病毒|HIV]]<ref name="Viral2011">{{cite journal | vauthors = Beard JA, Bearden A, Striker R | title = Vitamin D and the anti-viral state | journal = Journal of Clinical Virology | volume = 50 | issue = 3 | pages = 194–200 | date = March 2011 | pmid = 21242105 | pmc = 3308600 | doi = 10.1016/j.jcv.2010.12.006 }}</ref><ref>{{cite journal | vauthors = Spector SA | title = Vitamin D and HIV: letting the sun shine in | journal = Topics in Antiviral Medicine | volume = 19 | issue = 1 | pages = 6–10 | date = 2011 | pmid = 21852710 | pmc = 6148856 }}</ref>。維他命D的含量過低似乎是[[結核病|結核病]]的風險因素<ref>{{cite journal | vauthors = Nnoaham KE, Clarke A | title = Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis | journal = International Journal of Epidemiology | volume = 37 | issue = 1 | pages = 113–9 | date = February 2008 | pmid = 18245055 | doi = 10.1093/ije/dym247 | citeseerx = 10.1.1.513.3969 }}</ref>，在歷史上一直被用作治療用途<ref name=Tub2011>{{cite journal | vauthors = Luong K, Nguyen LT | title = Impact of vitamin D in the treatment of tuberculosis | url = https://archive.org/details/sim_american-journal-of-the-medical-sciences_2011-06_341_6/page/493 | journal = The American Journal of the Medical Sciences | volume = 341 | issue = 6 | pages = 493–8 | date = June 2011 | pmid = 21289501 | doi = 10.1097/MAJ.0b013e3182070f47 | s2cid = 18802134 }}</ref>。補充劑可稍微降低急性[[呼吸道感染|呼吸道感染]]的風險和嚴重程度，也可減輕[[哮喘|哮喘]]的惡化<ref name="Bergman">{{cite journal | vauthors = Bergman P, Lindh AU, Björkhem-Bergman L, Lindh JD | title = Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials | journal = PLOS ONE | volume = 8 | issue = 6 | pages = e65835 | year = 2013 | pmid = 23840373 | pmc = 3686844 | doi = 10.1371/journal.pone.0065835 | bibcode = 2013PLoSO...865835B }}</ref><ref name="bmj2017">{{cite journal | vauthors = Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz G, Esposito S, Ganmaa D, Ginde AA, Goodall EC, Grant CC, Griffiths CJ, Janssens W, Laaksi I, Manaseki-Holland S, Mauger D, Murdoch DR, Neale R, Rees JR, Simpson S, Stelmach I, Kumar GT, Urashima M, Camargo CA | display-authors = 6 | title = Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data | journal = BMJ | volume = 356 | pages = i6583 | date = February 2017 | pmid = 28202713 | pmc = 5310969 | doi = 10.1136/bmj.i6583 | url = http://www.bmj.com/content/356/bmj.i6583 | access-date = 2020-08-17 | archive-date = 2021-02-02 | archive-url = https://web.archive.org/web/20210202235636/https://www.bmj.com/content/356/bmj.i6583 | dead-url = no }}</ref>。這裡沒有證據表明維他命D影響5歲以下兒童的呼吸道感染<ref>{{cite journal | vauthors = Yakoob MY, Salam RA, Khan FR, Bhutta ZA | title = Vitamin D supplementation for preventing infections in children under five years of age | journal = The Cochrane Database of Systematic Reviews | volume = 11 | pages = CD008824 | date = November 2016 | pmid = 27826955 | pmc = 5450876 | doi = 10.1002/14651858.cd008824.pub2 }}</ref>。

[[2019冠状病毒病疫情|2019冠状病毒病疫情]]引起人們對維他命D缺乏症可能是呼吸道感染的危險因素的關注<ref name=bmj2017/><ref name="rhodes">{{cite journal | vauthors = Rhodes JM, Subramanian S, Laird E, Kenny RA | title = Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity | journal = Alimentary Pharmacology & Therapeutics | volume = 51 | issue = 12 | pages = 1434–1437 | date = June 2020 | pmid = 32311755 | pmc = 7264531 | doi = 10.1111/apt.15777 }}</ref><ref>{{cite journal | vauthors = Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, Bhattoa HP | title = Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths | journal = Nutrients | volume = 12 | issue = 4 | pages = 988 | date = April 2020 | pmid = 32252338 | pmc = 7231123 | doi = 10.3390/nu12040988 }}</ref><ref name="ebadi">{{cite journal | vauthors = Ebadi M, Montano-Loza AJ | title = Perspective: improving vitamin D status in the management of COVID-19 | journal = European Journal of Clinical Nutrition | volume = 74 | issue = 6 | pages = 856–859 | date = June 2020 | pmid = 32398871 | pmc = 7216123 | doi = 10.1038/s41430-020-0661-0 }}</ref>，但只有初步證據證明維他命D缺乏症和COVID-19感染之間存在直接關聯<ref>{{cite journal | vauthors = D'Avolio A, Avataneo V, Manca A, Cusato J, De Nicolò A, Lucchini R, Keller F, Cantù M | display-authors = 6 | title = 25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2 | journal = Nutrients | volume = 12 | issue = 5 | pages = 1359 | date = May 2020 | pmid = 32397511 | doi = 10.3390/nu12051359 | pmc = 7285131 }}</ref>。一項英國的研究發現，當對[[族群|族群]]等潛在的混雜因素進行調整時，先前所測量得到的維他命D水平跟COVID-19感染的發生率之間並沒有關聯<ref>{{cite journal | vauthors = Hastie CE, Mackay DF, Ho F, Celis-Morales CA, Katikireddi SV, Niedzwiedz CL, Jani BD, Welsh P, Mair FS, Gray SR, O'Donnell CA, Gill JM, Sattar N, Pell JP | display-authors = 6 | title = Vitamin D concentrations and COVID-19 infection in UK Biobank | journal = Diabetes & Metabolic Syndrome | volume = 14 | issue = 4 | pages = 561–565 | date = May 2020 | pmid = 32413819 | pmc = 7204679 | doi = 10.1016/j.dsx.2020.04.050 }}</ref>。維他命D缺乏症在許多COVID-19病例和死亡人數最多的國家中很普遍，例如美國，西班牙，英國，意大利和伊朗<ref name=rhodes/><ref name=ebadi/>。一份由UK NICE發表的證據摘要得出結論，這裡沒有任何證據支持以維他命D補充劑用作預防或治療COVID‑19<ref name="NICEJune2020">{{cite web |last1=NICE |title=Key messages {{!}}  COVID-19 rapid evidence summary: vitamin D for COVID-19 {{!}} Advice {{!}} NICE |url=https://www.nice.org.uk/advice/es28/chapter/Key-messages |website=www.nice.org.uk |accessdate=2020-06-29 |archive-date=2020-12-15 |archive-url=https://web.archive.org/web/20201215140516/https://www.nice.org.uk/advice/es28/chapter/Key-messages |dead-url=no }}</ref>。根據ClinicalTrials.gov，一些{{le|第二至四期臨床試驗|Phases of clinical research}}正在進行以評估使用維他命D預防或治療COVID‑19感染的用途。截至2020年5月，大多數研究都處於初步階段，尚未完成<ref name=vitD-clintrials>{{cite web|url=https://clinicaltrials.gov/ct2/results?cond=COVID-19&term=vitamin+D&cntry=&state=&city=&dist=|title=International clinical trials assessing vitamin D in people with COVID-19|publisher=ClinicalTrials.gov, US National Library of Medicine|date=May 2020|access-date=2020-05-20|archive-date=2020-10-06|archive-url=https://web.archive.org/web/20201006214952/https://clinicaltrials.gov/ct2/results?cond=COVID-19&term=vitamin+D&cntry=&state=&city=&dist=%2F|dead-url=no}}</ref>。大多數試驗的設計都是用以研究維他命D缺乏症的COVID-19感染者<ref name=vitD-clintrials/><ref>{{Cite web|url=https://doi.org/10.1038/s41598-020-77093-z|doi=10.1038/s41598-020-77093-z|title=nature research Scientific Reports 2020 10:20191 OPEN ACCESS Analysis of vitamin D level among asymptonmatic and critically ill COVID-19 patients and its correlation with inflammatory markers (CC BY 4.0 creative commons)|author=Anshul Jain, Rachna Chaurasia, Narendra Singh Sengar, Mayank Singh, Sachin Mahor & Sumit Narain|accessdate=2020-11-25|archive-date=2020-12-07|archive-url=https://web.archive.org/web/20201207122635/https://doi.org/10.1038/s41598-020-77093-z|dead-url=no}}</ref> 。

=== 其他狀況 ===
* '''糖尿病''' — 2014年的系統評價的結論是，現有的研究顯示，沒有證據表明維他命D<sub>3</sub>補充劑對葡萄糖穩態或[[糖尿病|糖尿病]]的預防有效<ref name="pmid25062463">{{cite journal | vauthors = Seida JC, Mitri J, Colmers IN, Majumdar SR, Davidson MB, Edwards AL, Hanley DA, Pittas AG, Tjosvold L, Johnson JA | display-authors = 6 | title = Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis | journal = The Journal of Clinical Endocrinology and Metabolism | volume = 99 | issue = 10 | pages = 3551–60 | date = October 2014 | pmid = 25062463 | pmc = 4483466 | doi = 10.1210/jc.2014-2136 | type = Review }}</ref>。2016年的一篇評論文章報告指，儘管越來越多的證據表明維他命D缺乏可能是糖尿病的風險因素，關於維他命D水平跟糖尿病的全面證據是互相矛盾的，這方面需要進一步研究<ref name="pmid26981182">{{cite journal | vauthors = Nakashima A, Yokoyama K, Yokoo T, Urashima M | title = Role of vitamin D in diabetes mellitus and chronic kidney disease | journal = World Journal of Diabetes | volume = 7 | issue = 5 | pages = 89–100 | date = March 2016 | pmid = 26981182 | pmc = 4781904 | doi = 10.4239/wjd.v7.i5.89 | type = Review }}</ref>。

* '''抑鬱症''' — 維他命D補充劑對於抑鬱症狀的臨床試驗普遍是低質量並沒有顯示整體效果，儘管小群分析顯示，對於具有臨床上明顯的抑鬱症狀或抑鬱障礙的參與者俱有中度療效<ref name="Shaffer">{{cite journal | vauthors = Shaffer JA, Edmondson D, Wasson LT, Falzon L, Homma K, Ezeokoli N, Li P, Davidson KW | display-authors = 6 | title = Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials | journal = Psychosomatic Medicine | volume = 76 | issue = 3 | pages = 190–6 | date = April 2014 | pmid = 24632894 | pmc = 4008710 | doi = 10.1097/psy.0000000000000044 }}</ref>。

* '''認知與癡呆''' — 一份臨床研究的系統性評價維他命D水平低與[[認知障礙|認知障礙]]之間存在著關聯，以及患上[[阿茲海默症|阿茲海默症]]有更高的風險。然而，較低的維他命D濃度也跟營養不良和戶外活動時間減少有關。因此無法確定對於增加存在認知障礙的替代解釋，以及由此而來的維他命D水平與認知之間的直接因果關係<ref name="pmid23008220">{{cite journal | vauthors = Balion C, Griffith LE, Strifler L, Henderson M, Patterson C, Heckman G, Llewellyn DJ, Raina P | display-authors = 6 | title = Vitamin D, cognition, and dementia: a systematic review and meta-analysis | journal = Neurology | volume = 79 | issue = 13 | pages = 1397–405 | date = September 2012 | pmid = 23008220 | pmc = 3448747 | doi = 10.1212/WNL.0b013e31826c197f }}</ref>。

* '''體重減少''' — 儘管假設維他命D補充劑在除了{{le|卡路里限制|Calorie restriction}}以外對[[肥胖症|肥胖症]]來說可能是一種有效的治療方法，一項系統性評價發現補充劑與體重或[[脂肪組織|脂肪量]]沒有關聯<ref>{{cite journal | vauthors = Pathak K, Soares MJ, Calton EK, Zhao Y, Hallett J | title = Vitamin D supplementation and body weight status: a systematic review and meta-analysis of randomized controlled trials | journal = Obesity Reviews | volume = 15 | issue = 6 | pages = 528–37 | date = June 2014 | pmid = 24528624 | doi = 10.1111/obr.12162 }}</ref>。2016年的一份[[元分析|元分析]]發現減輕體重可改善循環維他命D的狀態，這表明脂肪量可能跟血液中維他命D的水平成反比<ref name="mallard">{{cite journal | vauthors = Mallard SR, Howe AS, Houghton LA | title = Vitamin D status and weight loss: a systematic review and meta-analysis of randomized and nonrandomized controlled weight-loss trials | journal = The American Journal of Clinical Nutrition | volume = 104 | issue = 4 | pages = 1151–1159 | date = October 2016 | pmid = 27604772 | doi = 10.3945/ajcn.116.136879 | doi-access = free }}</ref>。

* '''懷孕''' — 懷孕期間的維他命D含量低跟[[妊娠糖尿病|妊娠糖尿病]]、[[妊娠毒血症|妊娠毒血症]]和細小嬰兒（胎齡）有關<ref name=Agh2013>{{cite journal | vauthors = Aghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, O'Beirne M, Rabi DM | title = Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies | journal = BMJ | volume = 346 | issue =  | pages = f1169 | date = March 2013 | pmid = 23533188 | doi = 10.1136/bmj.f1169 | doi-access = free }}</ref>。儘管孕婦在懷孕期間服用維他命D原則上會增加足月母親的維他命D的血液水平<ref name="palacios">{{cite journal | vauthors = Palacios C, De-Regil LM, Lombardo LK, Peña-Rosas JP | title = Vitamin D supplementation during pregnancy: Updated meta-analysis on maternal outcomes | journal = The Journal of Steroid Biochemistry and Molecular Biology | volume = 164 | pages = 148–155 | date = November 2016 | pmid = 26877200 | pmc = 5357731 | doi = 10.1016/j.jsbmb.2016.02.008 }}</ref>，但對於懷孕母親或嬰兒的全部益處尚未清楚<ref name=Agh2013/><ref name=palacios/><ref>{{cite journal | vauthors = Roth DE, Leung M, Mesfin E, Qamar H, Watterworth J, Papp E | title = Vitamin D supplementation during pregnancy: state of the evidence from a systematic review of randomised trials | journal = BMJ | volume = 359 | pages = j5237 | date = November 2017 | pmid = 29187358 | pmc = 5706533 | doi = 10.1136/bmj.j5237 }}</ref>。孕婦在妊娠期間攝取足夠的維他命D可能會降低[[妊娠毒血症|子癇前症]]<ref name="Palacios_2019">{{cite journal | vauthors = Palacios C, Kostiuk LK, Peña-Rosas JP | title = Vitamin D supplementation for women during pregnancy | journal = The Cochrane Database of Systematic Reviews | volume = 7 | pages = CD008873 | date = July 2019 | pmid = 31348529 | pmc = 3747784 | doi = 10.1002/14651858.CD008873.pub4 }}</ref>及積極免疫效果<ref name="Wagner_2012">{{cite journal | vauthors = Wagner CL, Taylor SN, Dawodu A, Johnson DD, Hollis BW | title = Vitamin D and its role during pregnancy in attaining optimal health of mother and fetus | journal = Nutrients | volume = 4 | issue = 3 | pages = 208–30 | date = March 2012 | pmid = 22666547 | pmc = 3347028 | doi = 10.3390/nu4030208 }}</ref>的風險。維他命D補充劑還可能降低妊娠糖尿病、體型過小的嬰兒<ref name="Palacios_2019" />以及其生長速度不良的風險<ref name="Bi_2018">{{cite journal | vauthors = Bi WG, Nuyt AM, Weiler H, Leduc L, Santamaria C, Wei SQ | title = Association Between Vitamin D Supplementation During Pregnancy and Offspring Growth, Morbidity, and Mortality: A Systematic Review and Meta-analysis | journal = JAMA Pediatrics | volume = 172 | issue = 7 | pages = 635–645 | date = July 2018 | pmid = 29813153 | pmc = 6137512 | doi = 10.1001/jamapediatrics.2018.0302 }}</ref>。孕婦通常不會服用維他命D的建議用量<ref name="Wagner_2012"/>。

=== 允許的健康聲明 ===
政府監管機構針對食物和膳食補充劑行業規定了於包裝上聲明某些允許範圍的健康聲明：
* [[歐洲食品安全局|歐洲食品安全局]] —
** 免疫系統的正常功能<ref name="EFSA1">{{cite journal |author=European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA) |title=Scientific opinion on the substantiation of health claims related to vitamin D and normal function of the immune system and inflammatory response (ID 154, 159), maintenance of normal muscle function (ID 155) and maintenance of normal cardiovascular function (ID 159) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 |journal=EFSA Journal |volume=8 |issue=2 |pages=1468–85 |year=2010 |doi=10.2903/j.efsa.2010.1468|doi-access=free }}</ref>；
** 正常炎症反應<ref name="EFSA1"/>；
** 正常肌肉功能<ref name="EFSA1"/>；
** 降低60歲以上人們跌倒的風險<ref name="EFSA2">{{cite journal |author=European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA) |title=Scientific opinion on the substantiation of a health claim related to vitamin D and risk of falling pursuant to Article 14 of Regulation (EC) No 1924/2006 |journal=EFSA Journal |volume=9 |issue=9 |pages=2382–2400 |year=2011 |doi=10.2903/j.efsa.2011.2382 |url=http://orbit.dtu.dk/files/6355745/prod11324398702885.Scientific.pdf |access-date=2020-08-17 |archive-date=2019-08-20 |archive-url=https://web.archive.org/web/20190820154317/https://orbit.dtu.dk/files/6355745/prod11324398702885.Scientific.pdf |dead-url=no }}</ref>。

* [[美國食品藥品監督管理局|美國食品藥品監督管理局]]（FDA）—
** 「充足的鈣和維他命D作為均衡飲食的一部分，加上體育鍛鍊，可以降低患上骨質疏鬆症的風險<ref>{{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-industry-food-labeling-guide |publisher=[[Food_and_Drug_Administration|Food and Drug Administration]] (FDA) |title=Guidance for Industry: Food Labeling Guide |date=January 2013 |accessdate=2020-08-17 |archive-date=2020-12-22 |archive-url=https://web.archive.org/web/20201222015608/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-industry-food-labeling-guide |dead-url=no }}{{PD-notice}}</ref>。」

* [[加拿大衛生部|加拿大衛生部]] —
** 充足的鈣質和恆常運動可以有助兒童和青少年獲得強壯的骨骼，並可以降低年長人士患骨質疏鬆症的風險。充足維他命D的攝入也是必要的<ref name="health_Canada">{{cite web |url=http://www.hc-sc.gc.ca/fn-an/label-etiquet/claims-reclam/assess-evalu/calcium_osteo-eng.php |publisher=Bureau of Nutritional Sciences Food Directorate, Health Products and Food Branch Health Canada |title=Health Canada Scientific Summary on the U. S. Health Claim Regarding Calcium and Osteoporosis |date=2000-05-01 |accessdate=2020-08-17 |archive-date=2016-12-03 |archive-url=https://web.archive.org/web/20161203155930/http://www.hc-sc.gc.ca/fn-an/label-etiquet/claims-reclam/assess-evalu/calcium_osteo-eng.php |dead-url=no }}</ref>。

* 其他可能提出指引的機構：日本的FOSHU<ref name="Japan Consumer Affairs Agency">{{cite web |url=http://www.caa.go.jp/en/pdf/syokuhin338.pdf |publisher=Japan Consumer Affairs Agency, Food Labelling Division |title=Regulatory Systems of Health Claims in Japan |date=2011-06-01 |access-date=2012-01-29 |archive-url=https://web.archive.org/web/20120306035916/http://www.caa.go.jp/en/pdf/syokuhin338.pdf |archive-date=2012-03-06 |url-status=dead |dead-url=no }}</ref>、和澳大利亞—紐西蘭<ref>{{cite web |url=http://www.nrv.gov.au/nutrients/vitamin%20d.htm |publisher=Australian Ministry of Health |title=Vitamin D |work=Nutrient Reference Values for Australia and New Zealand |date=2005-09-09 |url-status=dead |archive-url=https://web.archive.org/web/20120227070950/http://www.nrv.gov.au/nutrients/vitamin%20d.htm |archive-date=2012-02-27 |accessdate=2020-08-17 |dead-url=no }}</ref>。

=== 死亡率的所有成因 ===
初步發現維他命D<sub>3</sub>補充劑可降低老年人的死亡風險<ref name=Bj2014/><ref name=Aut2013/>，但效果尚未得到足夠明顯和足夠肯定使補充劑值得推薦<ref name=Futil2014/>。其他形式（維他命D<sub>2</sub>、阿法骨化醇和骨化三醇）似乎對死亡風險沒有任何有益的作用<ref name=Bj2014>{{cite journal | vauthors = Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M, Gluud C | display-authors = 6 | title = Vitamin D supplementation for prevention of mortality in adults | journal = The Cochrane Database of Systematic Reviews | volume = 1 | issue = 1 | pages = CD007470 | date = January 2014 | pmid = 24414552 | doi = 10.1002/14651858.CD007470.pub3 | type = Systematic review }}</ref>。血液中較高的水平似乎跟較低的死亡風險有關，但尚未清楚補充劑是否可以帶來這種益處<ref>{{cite journal | vauthors = Schöttker B, Jorde R, Peasey A, Thorand B, Jansen EH, Groot L, Streppel M, Gardiner J, Ordóñez-Mena JM, Perna L, Wilsgaard T, Rathmann W, Feskens E, Kampman E, Siganos G, Njølstad I, Mathiesen EB, Kubínová R, Pająk A, Topor-Madry R, Tamosiunas A, Hughes M, Kee F, Bobak M, Trichopoulou A, Boffetta P, Brenner H | display-authors = 6 | title = Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States | journal = BMJ | volume = 348 | issue = jun17 16 | pages = g3656 | date = June 2014 | pmid = 24938302 | pmc = 4061380 | doi = 10.1136/bmj.g3656 | author28 = Consortium on Health Ageing: Network of Cohorts in Europe the United States }}</ref>。過量及缺乏維他命D都會導致身體功能異常和過早衰老<ref>{{cite journal | vauthors = Tuohimaa P | s2cid = 40625040 | title = Vitamin D and aging | journal = The Journal of Steroid Biochemistry and Molecular Biology | volume = 114 | issue = 1–2 | pages = 78–84 | date = March 2009 | pmid = 19444937 | doi = 10.1016/j.jsbmb.2008.12.020 }}</ref><ref>{{cite journal | vauthors = Tuohimaa P, Keisala T, Minasyan A, Cachat J, Kalueff A | s2cid = 17462970 | title = Vitamin D, nervous system and aging | journal = Psychoneuroendocrinology | volume = 34 Suppl 1 | pages = S278-86 | date = December 2009 | pmid = 19660871 | doi = 10.1016/j.psyneuen.2009.07.003 }}</ref><ref name="pmid20590845">{{cite journal | vauthors = Manya H, Akasaka-Manya K, Endo T | title = Klotho protein deficiency and aging | journal = Geriatrics & Gerontology International | volume = 10 Suppl 1 | issue = Suppl 1 | pages = S80-7 | date = July 2010 | pmid = 20590845 | doi = 10.1111/j.1447-0594.2010.00596.x }}</ref>。血清降鈣素水平與死亡率的所有成因之間的關係是呈拋物線的<ref name="Ross_2011"/>。在黑色人口中出現維他命D含量較低的維他命D危害似乎較低於白色人口<ref name="Ross_2011" />。

== 維他命D過量 ==
{{main|{{le|維他命D毒性|Vitamin D toxicity}}}}
維他命D毒性很少<ref name="Holick_2007" />，這是由於高劑量的維他命D補充劑而非陽光引致的。維他命D毒性的下限尚未確定；然而根據一些研究，對於9-71歲的年齡組別的最高容許攝入量（UL）為每天4,000 [[國際單位|IU]]（每天100 µg）<ref name="RossetalAJCE2011">{{cite journal | vauthors = Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA | display-authors = 6 | title = The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know | journal = The Journal of Clinical Endocrinology and Metabolism | volume = 96 | issue = 1 | pages = 53–8 | date = January 2011 | pmid = 21118827 | pmc = 3046611 | doi = 10.1210/jc.2010-2704 }}</ref>，而其他研究得出的結論是，在健康的成年人中，持續攝入超過每天1,250μg（50,000 IU）可在幾個月後產生明顯的[[毒性|毒性]]，並可以增加血清25-羥基維他命D水平增加至150 ng/mL或更高<ref name="Holick_2007"/><ref name="Merck" />。那些患有某些疾病，例如原發性[[副甲狀腺功能亢進症|副甲狀腺功能亢進症]]<ref name="Vieth"/>對維他命D更加敏感，並為了應對維他命D營養增加時會產生[[高血鈣|高血鈣]]症，而孕婦在懷孕期間的高鈣血症可能會增加對維他命D作用的胎兒敏感性，及智力低下綜合症和臉部畸形<ref name="Vieth"/><ref>{{cite book |title=Tolerable Upper Intake Limits for Vitamins And Minerals |publisher=[[European_Food_Safety_Authority|European Food Safety Authority]] |date=December 2006 |isbn=978-92-9199-014-6 |url=http://www.efsa.europa.eu/en/home/oldsc/upper_level_opinions_full-part33.pdf |access-date=2020-08-18 |archive-date=2019-05-06 |archive-url=https://web.archive.org/web/20190506143914/http://www.efsa.europa.eu/en/home/oldsc/upper_level_opinions_full-part33.pdf |dead-url=yes }}</ref>。

突發性嬰兒高鈣血症（Idiopathic infantile hypercalcemia）是由於[[CYP24A1|CYP24A1]]的基因突變引致的，導致這種基因突變的嬰兒減少對維他命D的降解。患有這種基因突變的嬰兒對維他命D的敏感性增加，如果額外攝入的話會有發生高鈣血症的風險<ref name="pmid21675912">{{cite journal | vauthors = Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U, Misselwitz J, Klaus G, Kuwertz-Bröking E, Fehrenbach H, Wingen AM, Güran T, Hoenderop JG, Bindels RJ, Prosser DE, Jones G, Konrad M | display-authors = 6 | title = Mutations in CYP24A1 and idiopathic infantile hypercalcemia | journal = The New England Journal of Medicine | volume = 365 | issue = 5 | pages = 410–21 | date = August 2011 | pmid = 21675912 | pmc =  | doi = 10.1056/NEJMoa1103864 }}</ref><ref name="pmid31188746">{{cite journal | vauthors = De Paolis E, Scaglione GL, De Bonis M, Minucci A, Capoluongo E | title = CYP24A1 and SLC34A1 genetic defects associated with idiopathic infantile hypercalcemia: from genotype to phenotype | journal = Clinical Chemistry and Laboratory Medicine | volume = 57 | issue = 11 | pages = 1650–1667 | date = October 2019 | pmid = 31188746 | pmc =  | doi = 10.1515/cclm-2018-1208 | doi-access = free }}</ref>。這種紊亂可以持續到成年<ref name="pmid27588937">{{cite journal | vauthors = Tebben PJ, Singh RJ, Kumar R | title = Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment | journal = Endocrine Reviews | volume = 37 | issue = 5 | pages = 521–547 | date = October 2016 | pmid = 27588937 | pmc = 5045493 | doi = 10.1210/er.2016-1070 }}</ref>。

2015年發表的一篇評論指出，僅在25（OH）D血清濃度高於200 nmol/L時才報告有不良反應<ref name="pmid26288575">{{cite journal | vauthors = Dahlquist DT, Dieter BP, Koehle MS | title = Plausible ergogenic effects of vitamin D on athletic performance and recovery | journal = Journal of the International Society of Sports Nutrition | volume = 12 | issue =  | pages = 33 | year = 2015 | pmid = 26288575 | pmc = 4539891 | doi = 10.1186/s12970-015-0093-8 | type = Review }}</ref>。已知的涉及高鈣血症的已公佈毒性病例（其中已知的維他命D劑量和25-羥基維他命D水平為已知所有每天攝入≥40,000 IU（1,000 μg）<ref name=Vieth/>。

孕婦或哺乳期婦女在服用維他命D補充劑之前應諮詢醫生。FDA建議維他命D液體補充劑的製造商應清晰準確地將這些產品隨附的滴管標記為400 IU（1 IU為25 ng膽鈣化固醇/麥角鈣化固醇的生物等效物）。此外，對於用於嬰兒的產品，FDA建議滴管的容量不能超過400 IU<ref name="url_FDA_Caution_Vitamin_D_for_Infants">{{cite press release |url=https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm215150.htm |title=FDA Cautions on Accurate Vitamin D Supplementation for Infants |date=June 15, 2010 |publisher=Food and Drug Administration (FDA) |archive-url=https://wayback.archive-it.org/7993/20170112002746/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm215150.htm |archive-date=2017-01-12 |url-status=dead |access-date=2020-08-18 |dead-url=no }}{{PD-notice}}</ref>。對於嬰兒（由出生起至12個月），其允許的上限（無傷害的最大可以忍受量）設定為每天25 μg（1,000 IU）。對嬰兒來說，每天1,000mg的話，在一個月內會產生毒性<ref name="Merck">{{MerckManual|01|004|k||Vitamin D}}</ref>。受加拿大和美國政府委託，{{le|國家醫學科學院|National Academy of Medicine}}（IoM）{{as of|2010|11|30|lc=y}}已將1至3歲年齡段的容許上限（UL）增加至每天2,500 IU，4至8歲的兒童每天3,000 IU，而9-71歲以上則是每天4,000 IU（包括了孕婦或哺乳期婦女）<ref name="RossetalAJCE2011"/>。

骨化三醇本身以[[負反饋|負反饋]]周期自動調節，並且受到[[副甲狀腺激素|副甲狀腺激素]]、{{le|成纖維細胞生長因子23|Fibroblast growth factor 23}}、[[細胞因子|細胞因子]]、鈣質和磷酸鹽的影響<ref>{{cite journal | vauthors = Olmos-Ortiz A, Avila E, Durand-Carbajal M, Díaz L | title = Regulation of calcitriol biosynthesis and activity: focus on gestational vitamin D deficiency and adverse pregnancy outcomes | journal = Nutrients | volume = 7 | issue = 1 | pages = 443–80 | date = January 2015 | pmid = 25584965 | pmc = 4303849 | doi = 10.3390/nu7010443 }}</ref>。

=== 過量的影響 ===
維他命D過量會引致高鈣血症，這是維他命D毒性的強烈顯示 — 透過排尿和口渴的增加可以注意到這一點。若高鈣血症不獲處理，其結果會引致鈣質於軟組織和器官（如腎臟，肝臟和心臟）有過量的沉積，最後導致疼痛和器官損傷<ref name="Holick_2007"/><ref name="Brown_2008"/><ref name="Insel_2006">{{cite book |first1=Paul |last1=Insel |first2=Don |last2=Ross |first3=Melissa |last3=Bernstein |first4=Kimberley |last4=McMahon | name-list-format = vanc |title=Discovering Nutrition |url={{google books |plainurl=y |id=6IWHCgAAQBAJ}}|date=2015-03-18|publisher=Jones & Bartlett Publishers|isbn=978-1-284-06465-0}}</ref>。

維他命D過量的主要症狀都是高鈣血症的症狀，包括[[食欲不振|食欲不振]]、噁心和嘔吐。這些可能隨後是[[多尿症|多尿症]]、{{le|劇渴|Polydipsia}}、虛弱、失眠、緊張、[[癢|痕癢]]，最後是[[腎衰竭|腎衰竭]]。此外，它有可能發展為[[蛋白尿|蛋白尿]]、[[管型_(尿液)|管型尿液]]、{{le|氮質血症|Azotemia}}及{{le|轉移性鈣化|Metastatic calcification}}（尤其出現於腎臟）<ref name="Merck" />。維他命D毒性的其他症狀包括幼兒智力低下、骨骼異常生長和形成、腹瀉、易怒、體重減輕和嚴重抑鬱<ref name="Holick_2007"/><ref name="Insel_2006"/>。

維他命D毒性可透過停止維他命D補充劑並限制鈣的攝入來處理。腎臟損害可能是不可逆轉的。長時間暴露於陽光下通常不會引起維他命D毒性。在皮膚中產生的維他命D前體的濃度達到[[化學平衡|化學平衡]]，並且產生的任何進一步的維他命D都會被降解<ref name="Vieth">{{cite journal | vauthors = Vieth R | title = Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety | journal = The American Journal of Clinical Nutrition | volume = 69 | issue = 5 | pages = 842–56 | date = May 1999 | pmid = 10232622 | doi = 10.1093/ajcn/69.5.842 | url = http://www.ajcn.org/content/69/5/842.full.pdf | access-date = 2020-08-18 | archive-date = 2012-07-03 | archive-url = https://web.archive.org/web/20120703210532/http://www.ajcn.org/content/69/5/842.full.pdf | dead-url = no }}</ref>。

== 生物合成 ==
自然界中維他命D的合成取決於紫外線輻射的存在，以及隨後在肝臟和腎臟中的活化。許多動物從[[7-脫氫膽固醇|7-脫氫膽固醇]]合成維他命D<sub>3</sub>，許多真菌從[[麥角固醇|麥角固醇]]合成維生素D<sub>2</sub><ref name="pmid1297827">{{cite journal | vauthors = Holick MF | title = Evolutionary biology and pathology of vitamin D | journal = Journal of Nutritional Science and Vitaminology | volume = Spec No | issue =  | pages = 79–83 | year = 1992 | pmid = 1297827 | doi = 10.3177/jnsv.38.Special_79 | url = https://www.jstage.jst.go.jp/article/jnsv1973/38/Special/38_Special_79/_pdf | doi-access = free | access-date = 2020-08-19 | archive-date = 2020-12-22 | archive-url = https://web.archive.org/web/20201222015713/https://www.jstage.jst.go.jp/article/jnsv1973/38/Special/38_Special_79/_pdf | dead-url = no }}</ref><ref name="keegan"/>。

=== 光化學 ===
[[File:Vitamin_D_biosynthesis_in_fungi_and_animals.svg|thumb]]
[[File:Calcitriol-Biosynthese_2.svg|thumb]]至維生素D<sub>3</sub>的熱異構化。]]
把7-脫氫膽固醇轉化為維他命D<sub>3</sub>的轉化過程涉及兩個步驟<ref name="pmid3030826">{{cite journal | vauthors = Holick MF | title = Photosynthesis of vitamin D in the skin: effect of environmental and life-style variables | journal = Federation Proceedings | volume = 46 | issue = 5 | pages = 1876–82 | date = April 1987 | pmid = 3030826 | doi =  }}</ref><ref name="pmid24466410">{{cite journal | vauthors = Deluca HF | title = History of the discovery of vitamin D and its active metabolites | journal = BoneKEy Reports | volume = 3 | issue =  | pages = 479 | date = January 2014 | pmid = 24466410 | pmc = 3899558 | doi = 10.1038/bonekey.2013.213 }}</ref>：首先，7-脫氫膽固醇在6-電子[[順旋/對旋|順旋/對旋]]開環[[電環化反應|電環化反應]]中被紫外線以[[光分解作用|光分解作用]]光解；其產物為[[前维生素D3|前維生素D<sub>3</sub>]]。其次，維他命原D<sub>3</sub>自發地[[同分異構|同分異構]]至維生素D<sub>3</sub>（[[膽鈣化醇|膽鈣化醇]]），在[[σ遷移反應#例子|σ遷移反應]]中的{{le|異面與同面|Antarafacial and suprafacial}}。在室溫下，維生素原D<sub>3</sub>在有機溶劑中向維生素D<sub>3</sub>的轉化大約需要12天才能完成。皮膚中維他命原D<sub>3</sub>向維他命D<sub>3</sub>的轉化比有機溶劑中快約10倍<ref name="Holick_2004" />。

麥角固醇向維他命D<sub>2</sub>的轉化遵循相似的過程，透過光解形成維生素原D<sub>2</sub>，因而會異構化成維生素D<sub>2</sub><ref>{{cite journal |last1=Eyley |first1=Stephen C. |last2=Williams |first2=Dudley H. | name-list-format = vanc |title=Photolytic production of vitamin D. The preparative value of a photo-sensitiser |journal=Journal of the Chemical Society, Chemical Communications |date=1975 |issue=20 |pages=858a |doi=10.1039/C3975000858A}}</ref>。維他命原D<sub>2</sub>在甲醇中向維他命D<sub>2</sub>的轉化速率與維他命原D<sub>3</sub>相約。此過程於白色蘑菇中會更快<ref name="keegan" />{{rp|at=fig. 3}}。

=== 皮膚合成 ===
[[File:Skinlayers_zh.png|thumb]]
在大多數脊椎動物的皮膚中（包括人類）<ref>{{cite journal |pmid=12514284 |year=2003 |last1=Crissey |first1=SD |last2=Ange |first2=KD |last3=Jacobsen |first3=KL |last4=Slifka |first4=KA |last5=Bowen |first5=PE |last6=Stacewicz-Sapuntzakis |first6=M |last7=Langman |first7=CB |last8=Sadler |first8=W |last9=Kahn |first9=S |title=Serum concentrations of lipids, vitamin D metabolites, retinol, retinyl esters, tocopherols and selected carotenoids in twelve captive wild felid species at four zoos |url=https://archive.org/details/sim_journal-of-nutrition_2003-01_133_1/page/160 |volume=133 |issue=1 |pages=160–6 |journal=The Journal of nutrition}}</ref>，而裸鼴鼠似乎生來缺乏膽骨化醇<ref>{{cite journal |pmid=8384476 |year=1993 |last1=Yahav |first1=S |last2=Buffenstein |first2=R |title=Cholecalciferol supplementation alters gut function and improves digestibility in an underground inhabitant, the naked mole rat (Heterocephalus glaber), when fed on a carrot diet |url=https://archive.org/details/sim_british-journal-of-nutrition_1993-01_69_1/page/233 |volume=69 |issue=1 |pages=233–41 |journal=The British journal of nutrition |doi=10.1079/BJN19930025}}</ref>，因為其血液中檢測不到25（OH）D，對某些動物來說，其厚厚的毛皮阻擋了紫外線，而這些鳥獸也有自己的辦法，牠們把7-脫氫膽固醇分泌到毛皮表面，合成維他命D<sub>3</sub>後再自己舔回肚子裡<ref>{{cite book |first1=Sam D. |last1=Stout |first2=Sabrina C. |last2=Agarwal |last3=Stout |first3=Samuel D. |title=Bone loss and osteoporosis: an anthropological perspective |publisher=Kluwer Academic/Plenum Publishers |location=New York |year=2003 |isbn=0-306-47767-X}}</ref>。

維他命D<sub>3</sub>是由7-脫氫膽固醇以光化學方式產生的<ref name="pmid12514284">{{cite journal | vauthors = Crissey SD, Ange KD, Jacobsen KL, Slifka KA, Bowen PE, Stacewicz-Sapuntzakis M, Langman CB, Sadler W, Kahn S, Ward A | display-authors = 6 | title = Serum concentrations of lipids, vitamin d metabolites, retinol, retinyl esters, tocopherols and selected carotenoids in twelve captive wild felid species at four zoos | url = https://archive.org/details/sim_journal-of-nutrition_2003-01_133_1/page/160 | journal = The Journal of Nutrition | volume = 133 | issue = 1 | pages = 160–6 | date = January 2003 | pmid = 12514284 | doi = 10.1093/jn/133.1.160 | doi-access = free }}</ref>。維他命D<sub>3</sub>的前體，7-脫氫膽固醇的產量相對較高。7-脫氫膽固醇在290-315 nm的[[波長|波長]]下跟[[紫外線#科學上的分類|UVB光]]產生反應<ref>{{cite book |isbn=978-0-12-809965-0 |first=Michael F. |last=Holick |chapter=Chapter 4: Photobiology of Vitamin D |title=Vitamin D: Volume 1: Biochemistry, Physiology and Diagnostics |edition=4th |publisher=Academic Press |place=London, UK|editor-last1=Feldman|editor-first1=David|editor-last2=Wesley Pike|editor-first2=J.|editor-last3=Bouillon|editor-first3=Roger|editor-last4=Giovannucci|editor-first4=Edward|editor-last5=Goltzman|editor-first5=David|editor-last6=Hewison|editor-first6=Martin |date=2018| name-list-format = vanc}}</ref>。這些波長不僅存在於太陽光中，而且存在於[[室內曬黑|室內曬黑]]中的紫外線燈發出的光（那是主要在[[紫外線#科學上的分類|UVA]]的光譜中產生紫外線，但通常會產生UVB總量的4％至10％）。透過窗戶暴露的陽光不足，因為玻璃幾乎會完全阻擋了UVB的光線<ref>{{cite news |url=https://www.nytimes.com/2005/05/17/science/17qna.html |title=Q&A Sunshine Vitamin D |first=C. Claiborne |last=Ray |name-list-format=vanc |newspaper=[[The_New_York_Times|The New York Times]] |date=2005-05-17 |access-date=2013-03-08 |archive-url=https://web.archive.org/web/20130221030710/http://www.nytimes.com/2005/05/17/science/17qna.html |archive-date=2013-02-21 |dead-url=no }}</ref><ref name=iuva>{{cite web |url=http://iuva.org/uv-faqs |title=UV FAQs |vauthors=Bolton J |publisher=International Ultraviolet Association |url-status=dead |archive-url=https://web.archive.org/web/20130530132909/http://iuva.org/uv-faqs |archive-date=2013-05-30 |accessdate=2020-08-19 |dead-url=no }}</ref>。

面部、手臂和腿部的皮膚適量地暴露於陽光下，可以產生足夠分量的維他命D，而每星期兩次，每次平均5–30分鐘，又或大約25％的時間，可將曬傷程度降至最低。皮膚顏色越深，日光越微弱，則需要暴露的時間越長。暴露在紫外線下不可能引致維他命D過量：皮膚達到平衡時，該維他命降解的速度與其產生的速度一樣快<ref name="Holick_2007"/><ref>{{cite journal |author=Holick MF |s2cid=87725403 |date=February 2002 |title=Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health |journal=Current Opinion in Endocrinology, Diabetes and Obesity |volume=9 |issue=1 |pages=87–98 |doi=10.1097/00060793-200202000-00011}}</ref><ref>{{cite journal | vauthors = Holick MF | title = Sunlight and vitamin D: both good for cardiovascular health | journal = Journal of General Internal Medicine | volume = 17 | issue = 9 | pages = 733–5 | date = September 2002 | pmid = 12220371 | pmc = 1495109 | doi = 10.1046/j.1525-1497.2002.20731.x }}</ref>。

[[防曬油|防曬油]]把紫外線吸收或反射，並防止大部分紫外線到達皮膚<ref name=holick87/>。根據UVB光譜得出的防曬係數（SPF）為8的防曬霜可使維他命D的合成能力降低95％，而SPF 15則使其降低98％<ref name="Ross_2011">{{cite book |author=Institute of Medicine (IoM) |chapter=8, Implications and Special Concerns |chapterurl=https://www.ncbi.nlm.nih.gov/books/NBK56078/ |veditors=Ross AC, Taylor CL, Yaktine AL, Del Valle HB |title=Dietary Reference Intakes for Calcium and Vitamin D |publisher=National Academies Press |year=2011 |isbn=978-0-309-16394-1 |pmid=21796828 |doi=10.17226/13050 |url=https://www.ncbi.nlm.nih.gov/books/NBK56070/ |series=The National Academies Collection: Reports funded by National Institutes of Health |access-date=2020-08-19 |archive-date=2021-01-26 |archive-url=https://web.archive.org/web/20210126052042/https://www.ncbi.nlm.nih.gov/books/NBK56070/ |dead-url=no }}</ref>。

皮膚由兩個主要層級組成：主要由[[結締組織|結締組織]]組成，稱為[[真皮|真皮]]的內層，以及外面比較薄的[[表皮_(皮膚)|表皮]]<ref name="nci">{{cite web |url=https://training.seer.cancer.gov/melanoma/anatomy/ |title=Anatomy of the skin |publisher=National Cancer Institute, US National Institutes of Health, Bethesda |date=2016 |access-date=2016-12-19 |archive-date=2021-01-28 |archive-url=https://web.archive.org/web/20210128090055/https://training.seer.cancer.gov/melanoma/anatomy/ |dead-url=no }}</ref>。厚表皮包括了手掌和腳底的五個層級組成，從外到內，它們是：[[角質層|角質層]]、[[透明層|透明層]]、[[顆粒層|顆粒層]]、[[棘層|棘層]]和[[基底層|基底層]]；維他命D於兩個最內層中產生[[角質形成細胞|角質形成細胞]]<ref>{{cite web |title=Vitamin D and Skin Health |url=http://lpi.oregonstate.edu/mic/health-disease/skin-health/vitamin-D |website=LINUS PAULING INSTITUTE Micronutrient Information Center |publisher=Oregon State University |access-date=2017-03-30 |date=2016-11-07 |archive-date=2020-11-29 |archive-url=https://web.archive.org/web/20201129113936/https://lpi.oregonstate.edu/mic/health-disease/skin-health/vitamin-D |dead-url=no }}</ref>，分別是基底層和棘層<ref name="holick87">{{cite journal | vauthors = Holick MF, Smith E, Pincus S | title = Skin as the site of vitamin D synthesis and target tissue for 1,25-dihydroxyvitamin D3. Use of calcitriol (1,25-dihydroxyvitamin D3) for treatment of psoriasis | journal = Archives of Dermatology | volume = 123 | issue = 12 | pages = 1677–1683a | date = December 1987 | pmid = 2825606 | doi = 10.1001/archderm.1987.01660360108022 }}</ref>。

7-脫氫膽固醇在波長在270-300納米（峰值295-297納米）之間的紫外線照射下可以變構轉化為維他命D<sub>3</sub><ref name="Hume Lucas Smith 1927 362-367">{{cite journal |first1=Eleanor Margaret |last1=Hume |first2=Nathaniel Sampson |last2=Lucas |first3=Hannah Henderson |last3=Smith |title=On the Absorption of Vitamin D from the Skin |url=https://archive.org/details/sim_biochemical-journal_1927_21_2/page/362 |journal=Biochemical Journal |volume=21 |issue=2 |pages=362–367 |year=1927 |pmid=16743844 |pmc=1251921}}</ref>，在陽光中的紫外線指數（夜間的紫外線指數為0，熱帶、高原地區、晴天時的紫外線指數為15），＞3的時候或在日光浴燈下才會有這種能發揮作用的紫外線。日光浴燈產生的紫外線大多數是長波的UVA，而產生維他命D<sub>3</sub>所需要的是中波紫外線（UVB）佔其中的4-10%，從地域上說，熱帶地區的人每天都可以產生維他命D<sub>3</sub>，溫帶地區的人在春夏季節時也可以，而極地地區的人們，該處的紫外線強度幾乎不可能使其產生維他命D<sub>3</sub><ref>{{Cite web |url=http://www.nap.edu/openbook.php?record_id=13050&page=104 |title=Dietary Reference Intakes for Calcium and Vitamin D (2011)Page 104 |accessdate=2012-01-02 |archive-date=2015-01-18 |archive-url=https://web.archive.org/web/20150118070350/http://www.nap.edu/openbook.php?record_id=13050&page=104 |dead-url=no }}</ref>。血清25（OH）D的平均濃度的差異似乎應該隨緯度升高而降低，然而實際上並不跟預期的一致，例如在夏天，加拿大北部地區的日照強度與時間加起來比赤道地區的還要強，而且高緯度地區的生物於春夏季或秋季都有可能形成並儲存足夠的維他命D，UVB產生的維他命D功能（無法控制非酶促反應的異構作用）非常強大，以至於皮膚形成多餘的維他命D<sub>3</sub>必須及時降解掉，以免其產生毒性，最終使維他命D的合成和降解達到了平衡的狀態<ref name="Holick M 1995 638S–645S">{{cite journal |author=Holick MF |title=Environmental factors that influence the cutaneous production of vitamin D |journal=[[The_American_Journal_of_Clinical_Nutrition|The American Journal of Clinical Nutrition]] |volume=61 |issue=3 Suppl |pages=638S–645S |pmid=7879731 |url=http://www.ajcn.org/content/61/3/638S.full.pdf |date=March 1995 |access-date=2012-01-02 |archive-date=2012-07-03 |archive-url=https://web.archive.org/web/20120703210504/http://www.ajcn.org/content/61/3/638S.full.pdf |dead-url=no }}</ref>。

=== 身體合成 ===
維他命D透過血流輸送到肝臟，在那裏轉化為激素前體骨化二醇，循環中的骨化二醇在腎臟和單核巨噬細胞系統中轉化為骨化三醇，從而成為具有生物活性的維他命D，而在免疫系統中，骨化三醇（1,25(OH)D）發揮着細胞因子的作用，保護機體抵抗微生物入侵<ref name="Adams&Hewison2010">{{cite journal |last1=Adams |first1=J. S. |last2=Hewison |first2=M. |title=Update in Vitamin D |journal=Journal of Clinical Endocrinology & Metabolism |volume=95 |issue=2 |pages=471–8 |year=2010 |pmid=20133466 |pmc=2840860 |doi=10.1210/jc.2009-1773}}</ref>。腎臟將骨化二醇轉化為骨化三醇釋放到血液中，跟維他命的結合蛋白結合，轉送到靶器官<ref name="River" />。骨化三醇透過激活維他命D受體發揮生物學效應，VDR存在於靶細胞表面<ref name="River" />的活化VDR可以作為轉錄因子，調節運載蛋白（如TRPV6和[[鈣結合蛋白|鈣結合蛋白]]）的表達，從而參與小腸內鈣的吸收<ref name=Bouillon2003 />。VDR屬於核受體中類固醇／甲狀腺素受體超級家族，可以在大多數器官中表達，包括腦部、心臟、皮膚、前列腺和乳腺等，VDR在小腸、骨骼、腎臟和甲狀旁腺的表達能夠保證血鈣血磷代謝正常（這與甲狀旁腺激素和降鈣素協同作用），並可以維持正常骨的質量<ref name="Sun">{{cite journal |pmid=15585788 |year=2004 |last1=Holick |first1=MF |title=Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease |volume=80 |issue=6 Suppl |pages=1678S–88S |journal=[[The_American_Journal_of_Clinical_Nutrition|The American Journal of Clinical Nutrition]] |url=http://www.ajcn.org/content/80/6/1678S.long |access-date=2012-01-02 |archive-date=2012-08-20 |archive-url=https://web.archive.org/web/20120820061406/http://www.ajcn.org/content/80/6/1678S.long |dead-url=no }}</ref>。維他命D提高了腎上腺髓質細胞酪氨酸羥化酶的表達，也參與了神經營養因子、一氧化氮等物質的合成，並能提高機體穀胱甘肽的水平<ref name="pmid9011759" />。現在有意見認為VDR也干預了細胞增殖和分化，而且對免疫系統也起了很強的免疫促進作用，很多種白血球細胞包括單核細胞、T細胞、B細胞都能夠表達VDR<ref name="PDR" />。VDR除了可以激活某些基因外，還有其他一些作用機理已經闡明，其中一個非常重要效果是，它可以抑制刺蝟激素（一種參與器官形成的激素）的信號轉導<ref name=Sarkar2010>{{cite journal |author=Sarkar FH, Li Y, Wang Z, Kong D. |title=The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer |journal=Cancer Metastasis Reviews |year=2010 |volume=29 |issue=3 |pages=383–64 |pmid=20711635 |pmc=2974632}}</ref><ref>{{cite web |url=http://www.medscape.com/viewarticle/713649_3 |title=Hedgehog signaling and Vitamin D |publisher=Medscape.com |date=2009-12-18 |accessdate=2010-03-25 |archive-date=2013-05-11 |archive-url=https://web.archive.org/web/20130511140755/http://www.medscape.com/viewarticle/713649_3 |dead-url=no }}</ref>。

維他命D最重要的功能就是保持骨骼中鈣質的平衡，它可以增強小腸對鈣質的吸收、提高破骨細胞的數量和增強骨吸收、維持血鈣及血磷濃度以維持正常骨量，並調整甲狀旁腺激素來維持血鈣平衡。缺乏維他命D會引致鈣磷代謝異常，導致骨質密度降低、骨質流失（骨質疏鬆症），甚至是骨折。

=== 演化 ===
維他命D只能透過光化學過程合成。海洋中的浮游植物（例如[[鈣板金藻|鈣板金藻]]和[[赫氏圓石藻|赫氏圓石藻]]）已經超過5億年以來都是一直利用紫外線進行光合作用來合成維他命D。海洋中的原始脊椎動物可以把海洋中的鈣質吸收到其骨骼中，並食用富含維他命D的浮游生物來吸收該種維他命。

陸地上的脊椎動物已經超過3.5億年來以光合作用合成維他命D<ref name="isbn0-452-29688-9">{{cite book |url={{google books |plainurl=y |id=P4xbcP19H0AC  |pages = 27}}|title=The Vitamin D Solution: A 3-Step Strategy to Cure Our Most Common Health Problems|last=Holick|first=Michael F.|date=2010-04-01|publisher=Penguin Publishing Group|isbn=978-1-101-22293-5| name-list-format = vanc}}</ref>。
牠們的鈣化骨骼需要植物以外的另一種維他命D來源。牠們必須攝取它，或暴露於陽光下才能在皮膚中進行光合作用<ref name="pmid1297827"/><ref name="Holick_2004">{{cite journal | vauthors = Holick MF | title = Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis | url = https://archive.org/details/sim_american-journal-of-clinical-nutrition_2004-03_79_3/page/362 | journal = The American Journal of Clinical Nutrition | volume = 79 | issue = 3 | pages = 362–71 | date = March 2004 | pmid = 14985208 | doi = 10.1093/ajcn/79.3.362 | doi-access = free }}</ref>。對於硬骨類脊椎動物來說，離開富含鈣質的海水來到陸地上，維他命D對保證其骨骼中的鈣質來說非常重要，由於維他命D的合成必須要有紫外線參與，所以早期登陸岸上的的脊椎動物必須把身體暴露於陽光下或者補充富含維他命D的食物來滿足其身體對維他命D的需求<ref name="Holick_2004" />。

在鳥類和帶有皮毛的哺乳類動物中，皮毛或羽毛會阻擋紫外線到達皮膚。相反，維他命D是由沉積於其羽毛或皮毛上皮膚的油性分泌物產生的，在修飾過程中通過口服獲得該種維他命<ref name="AgarwalStout2011">{{cite book |first1=Sabrina C. |last1=Agarwal |first2=Samuel D. |last2=Stout | name-list-format = vanc |title=Bone Loss and Osteoporosis: An Anthropological Perspective |url={{google books |plainurl=y |id=_JV3BQAAQBAJ}}|date=2011-06-28|publisher=Springer Science & Business Media|isbn=978-1-4419-8891-1 |quote=從猿類和猴子的生物學角度來看，可以理解其高25(OH)D濃度和相對較高的維他命D需求量是可以理解的—-牠們的身體表面面積通常相對於人類來說質量較大，而且牠們都是精通梳理毛髮的動物，經其口腔消耗從皮毛分泌的油脂中產生的維他命D。儘管人類皮膚中產生的許多維他命D被直接吸收，但鳥類和有毛皮的動物在梳理毛髮的時候，會從口腔獲得大部分維他命D（1946年—Bicknell和Prescott；1999年—Carpenter和Zhao）。維他命D是由皮膚油脂分泌到皮毛中產生的。口服的紫外線暴露的皮膚分泌物是許多動物獲取維他命D「營養素」的方式。儘管弗雷澤（Fraser，1983）認為皮膚吸收維他命D可能更自然，但從動物身上讓我們知道，口服維他命D具有同樣的生理意義。由於可以從暴露於紫外線的人體汗液和皮膚分泌物，也可以認為早期人類也可以透過舔皮膚經口腔獲得的某些維他命D。|archive-url=https://web.archive.org/web/20060129105712/http://www.direct-ms.org/pdf/VitDVieth/Vieth%20Anthropology%20vit%20D.pdf |archive-date=2006-01-29 |url-status=live}}</ref>。然而，由於無法檢測到血清中25-OH維他命D水平，因此某些動物（如[[裸鼴鼠|裸鼴鼠]]），是天然膽鈣化醇缺乏症的動物<ref>{{cite journal | vauthors = Yahav S, Buffenstein R | title = Cholecalciferol supplementation alters gut function and improves digestibility in an underground inhabitant, the naked mole rat (Heterocephalus glaber), when fed on a carrot diet | url = https://archive.org/details/sim_british-journal-of-nutrition_1993-01_69_1/page/233 | journal = The British Journal of Nutrition | volume = 69 | issue = 1 | pages = 233–41 | date = January 1993 | pmid = 8384476 | doi = 10.1079/BJN19930025 | doi-access = free }}</ref>。

=== 工業合成 ===
維他命D<sub>3</sub>（膽鈣化固醇）的生產是通過將[[7-脫氫膽固醇|7-脫氫膽固醇]]暴露於UVB光下，然後進行純化來生產的<ref name="Holick05">{{cite journal | vauthors = Holick MF | title = The vitamin D epidemic and its health consequences | journal = The Journal of Nutrition | volume = 135 | issue = 11 | pages = 2739S–48S | date = November 2005 | pmid = 16251641 | doi = 10.1093/jn/135.11.2739S | url = http://jn.nutrition.org/content/135/11/2739S.full.pdf | quote = [Vitamin D3] is produced commercially by extracting 7-dehydrocholesterol from wool fat, followed by UVB irradiation and purification [...] [Vitamin D2] is commercially made by irradiating and then purifying the ergosterol extracted from yeast | access-date = 2012-01-02 | archive-date = 2017-11-18 | archive-url = https://web.archive.org/web/20171118043538/http://jn.nutrition.org/content/135/11/2739S.full.pdf | dead-url = no }}</ref>。7-脫氫膽固醇是魚類器官特別是肝臟中的天然物質<ref>{{cite journal | vauthors = Takeuchi A, Okano T, Sayamoto M, Sawamura S, Kobayashi T, Motosugi M, Yamakawa T | title = Tissue distribution of 7-dehydrocholesterol, vitamin D3 and 25-hydroxyvitamin D3 in several species of fishes | journal = Journal of Nutritional Science and Vitaminology | volume = 32 | issue = 1 | pages = 13–22 | date = February 1986 | pmid = 3012050 | doi = 10.3177/jnsv.32.13 | url = https://www.jstage.jst.go.jp/article/jnsv1973/32/1/32_1_13/_pdf | doi-access = free | access-date = 2020-08-20 | archive-date = 2018-11-01 | archive-url = https://web.archive.org/web/20181101013656/https://www.jstage.jst.go.jp/article/jnsv1973/32/1/32_1_13/_pdf | dead-url = no }}</ref>，或廣泛存在於綿羊的羊毛脂（[[綿羊油|綿羊油]]）以及其他動物毛髮中的天然物質。

維他命D<sub>2</sub>（麥角鈣化醇）的生產方法也類似，利用酵母或蘑菇中的麥角甾醇作為起始原材料<ref name="Holick05"/><ref name=keegan/>。

==== 合成機制 ====
{| class="wikitable"
| 皮膚中的7-脫氫膽固醇經紫外線照射後6號電子發生順旋電環化反應，形成前維他命D<sub>3</sub>。
| [[File:Calcitriol-Biosynthese_1_engl.svg|400px]]
|-
| 同時前維他命D<sub>3</sub>透過異側氫原子σ移位重排，變構產生維他命D<sub>3</sub>。在室溫的條件下，由前維他命D<sub>3</sub>轉化至維他命D<sub>3</sub>需時12天完成。
| [[File:Calcitriol-Biosynthese_2.svg|400px]]
|-
| 不論是自身合成的還是食物中攝取到的維他命D<sub>3</sub>，都要在肝臟中處理，在25位碳上加上一個羥基，從而形成25-羥基膽骨化醇（骨化二醇／25（OH）D）<ref>{{cite journal|doi = 10.1073/pnas.0402490101|author = Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW|title = Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase|journal = Proc Natl Acad Sci U S A|volume = 101|issue = 20|pages = 7711–7715|date = 2004-05-18|pmid = 15128933|pmc = 419671|bibcode=2004PNAS..101.7711C}}</ref>。這個過程是由肝臟微粒體酶——25羥化酶催化的，25（OH）D一經合成，便釋放到血液中，與α-球蛋白結合，就成為所謂的維他命D結合蛋白α-球蛋白結合體<ref>Laing, CJ and Cooke, NE. ''Vitamin D Binding Protein.'' In: '''Vitamin D (Vol. 1)''' David Feldman, Francis H. Glorieaux, J. Wesley Pike (eds.). Elsevier Press. 2005. pp 117-134.</ref>。
| [[File:Cholecalciferol_to_calcidiol_CH3.svg|400px]]
|-
| 25（OH）D輸送到腎臟近段的腎小管，在那裏發生1-α（分子下角右邊的那個碳原子）位羥化而形成骨化三醇（1,25（OH）2D），可以有效的激活維他命D受體（VDR），活化的VDR介導維他命D所需要發揮的主要功能。25（OH）D向1,25（OH）2D的轉換需要25D31-α羥化酶，血液中甲狀旁腺激素水平升高可以提高這種酶的合成（當血鈣血磷降低時也可以）。
| [[File:Calcidiol_to_calcitriol_CH3.svg|400px]]
|}

== 作用機理 ==
=== 代謝活化 ===
[[File:Cholecalciferol_to_calcidiol_CH3.svg|thumb]]至{{le|骨化二醇|Calcifediol}}的肝臟羥基化。]]
[[File:Calcidiol_to_calcitriol_CH3.svg|thumb]]的腎臟羥基化。]]
維他命D通過血流輸送到肝臟，它在這裡被轉化為前激素降鈣素，然後循環中的骨化二醇可在腎臟中轉化為骨化三醇，那是腎臟中維他命D的生物活性形式<ref name="Adams&Hewison2010" />。

無論是在皮膚中合成還是透過攝取而成，維他命D於[[肝臟|肝臟]]中的位置25（分子的右上方）[[羥基化|羥基化]]，以形成25-羥基膽鈣化固醇（骨化二醇／25（OH）D）<ref name=Bikle>{{cite journal | vauthors = Bikle DD | title = Vitamin D metabolism, mechanism of action, and clinical applications | journal = Chemistry & Biology | volume = 21 | issue = 3 | pages = 319–29 | date = March 2014 | pmid = 24529992 | pmc = 3968073 | doi = 10.1016/j.chembiol.2013.12.016 }}</ref>。該反應由{{le|CYP2R1|CYP2R1}}這種人類基因[[微粒體|微粒體]]酶的產物催化，並由[[肝細胞|肝細胞]]表達<ref>{{cite journal | vauthors = Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW | title = Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 101 | issue = 20 | pages = 7711–5 | date = May 2004 | pmid = 15128933 | pmc = 419671 | doi = 10.1073/pnas.0402490101 | bibcode = 2004PNAS..101.7711C }}</ref>。當製成後，該產物會被釋放到[[血漿|血漿]]中，並與稱為{{le|維他命D結合蛋白|Vitamin D-binding protein}}的α-球蛋白載體蛋白結合<ref>{{cite book |vauthors=Laing CJ, Cooke NE |chapter=Section I: Ch. 8: Vitamin D Binding Protein |veditors=Feldman D, Glorieux FH, Pike JW |title=Vitamin D |volume=1 |publisher=Academic Press |edition=2 |year=2004 |isbn=978-0122526879 |pages=117–134 | chapter-url = {{google books |plainurl=y |id=5c66r0KrPUMC}}}}</ref>。骨化二醇被輸送到腎臟的近端小管，它在1-α位置（分子的右下角）被羥基化，形成骨化三醇（1,25-二羥基膽鈣化固醇，1,2,5（OH）<sub>2</sub>D）。骨化二醇向骨化三醇的轉化是通過酶[[CYP27B1|CYP27B1]]（25-羥基維他命D<sub>3</sub>1-α-羥化酶）催化，這是人類基因「CYP27B1」的產物。CYP27B1活性的增加是透過甲狀旁腺激素以及低鈣或低磷酸鹽的環境<ref name="Norman_2008"/><ref name="Adams&Hewison2010" />。

在腎臟的最後轉化步驟之後，骨化三醇會釋放到循環系統中。通過與維他命D結合蛋白的結合，骨化三醇被輸送到整個身體，包括腸道，腎臟和骨骼這些經典目標器官<ref name="River" />。骨化三醇是{{le|維他命D受體|Vitamin D receptor}}中最有效的天然[[配體|配體]]，它介導維他命D的大部分生理作用<ref name="Norman_2008"/><ref name="Adams&Hewison2010" />。除腎臟外，骨化三醇還由某些其他細胞合成，包括[[免疫系統|免疫系統]]中的[[单核细胞|單核白血球]]至[[巨噬細胞|巨噬細胞]]。當單核白血球跟巨噬細胞合成時，骨化三醇局部作為[[細胞因子|細胞因子]]，通過刺激[[先天免疫系統|先天免疫系統]]調節針對微生物入侵者的身體防禦<ref name="Adams&Hewison2010" />。

=== 鈍化 ===
骨化二醇和骨化三醇的活性可通過{{le|維他命D<sub>3</sub>24-羥化酶|Vitamin D3 24-hydroxylase}}的24位，分別形成分別骨鈣化醇（secalciferol）和（calcitetrol）進行羥基化來降低<ref name=Bikle/>。

=== 基質之間的差異 ===
維他命D<sub>2</sub>（麥角鈣化醇）和維他命D<sub>3</sub>（膽鈣化醇）具有如上所述的相似作用機理<ref name=Bikle/>。維他命D<sub>2</sub>產生的代謝物於英文名稱上有時以「er-」或「ergo」作為為前綴來命名，使其與基於D<sub>3</sub>的配對物作區分<ref name=nomen-d>{{cite journal | vauthors =  | title = IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN): Nomenclature of vitamin D. Recommendations 1981 | journal = European Journal of Biochemistry | volume = 124 | issue = 2 | pages = 223–7 | date = May 1982 | pmid = 7094913 | doi = 10.1111/j.1432-1033.1982.tb06581.x }}</ref>。
* 由維他命D<sub>2</sub>產生的代謝物往往與維他命D結合蛋白的結合較差。
* 維他命D<sub>3</sub>可以通過[[CYP27A1|CYP27A1]]羥化為骨化二醇，但是維他命D<sub>2</sub>就不能。
* 麥角鈣化醇可以在位置24直接被羥基化。這種羥基化還導致更大程度的滅活：在24-羥基化作用後骨化三醇的活性降至原始水平的60％<ref>{{cite journal | vauthors = Holick MF, Kleiner-Bossaller A, Schnoes HK, Kasten PM, Boyle IT, DeLuca HF | title = 1,24,25-Trihydroxyvitamin D3. A metabolite of vitamin D3 effective on intestine | journal = The Journal of Biological Chemistry | volume = 248 | issue = 19 | pages = 6691–6 | date = October 1973 | pmid = 4355503 }}</ref>，骨鈣三醇轉化為鈣鈣鈦礦的活性降低了10倍<ref>{{cite journal | vauthors = Horst RL, Reinhardt TA, Ramberg CF, Koszewski NJ, Napoli JL | title = 24-Hydroxylation of 1,25-dihydroxyergocalciferol. An unambiguous deactivation process | journal = The Journal of Biological Chemistry | volume = 261 | issue = 20 | pages = 9250–6 | date = July 1986 | pmid = 3013880 }}</ref>。

== 歷史 ==
{{See|維他命#歷史}}

美國研究人員{{le|埃爾默·麥柯倫|Elmer McCollum}}和{{le|瑪格麗特·戴維斯|Marguerite Davis}}於1914年在[[魚肝油|魚肝油]]中發現了一種物質，後來稱為「[[維他命A|維他命A]]」<ref name="Wolf_2004"/>。英國醫生[[爱德华·梅兰比|爱德华·梅兰比]]留意到以魚肝油餵養的狗沒有發展成佝僂病，並得出結論指它是維他命A，或可以預防這種疾病的一個密切相關的因素。1922年，麥柯倫測試了改良的魚肝油，其中維他命A被破壞了<ref name="Wolf_2004"/>。經改良的魚肝油治癒了患病的狗隻，因此麥柯倫得出結論，魚肝油中治癒佝僂病的因素不同於維他命A<ref>{{cite web |url=http://www.thestar.com/printarticle/239341 |title=Age-old children's disease back in force |publisher=Thestar.com |date=2007-07-25 |accessdate=2010-08-24 |archive-date=2008-05-17 |archive-url=https://web.archive.org/web/20080517044348/http://www.thestar.com/printArticle/239341 |dead-url=no }}</ref><ref>{{cite news |url=http://articles.latimes.com/2006/jul/24/health/he-esoterica24 |author=Elena Conis |title=Fortified foods took out rickets |work=[[Los_Angeles_Times|Los Angeles Times]] |date=2006-07-24 |accessdate=2010-08-24 |archive-date=2012-03-02 |archive-url=https://web.archive.org/web/20120302045431/http://articles.latimes.com/2006/jul/24/health/he-esoterica24 |dead-url=no }}</ref><ref>McClean, Franklin C.; Budy, Ann M. "Vitamin A, Vitamin D, Cartilage, Bones, and Teeth" in Harris, Robert S. (1963). ''Vitamins and Hormones'', volume 21, pp. 51–52. London: Academic Press [http://books.google.com/books?id=gGb7vm2SapcC&lpg=PA52&pg=PA51#v=onepage Partial view] {{Wayback|url=http://books.google.com/books?id=gGb7vm2SapcC&lpg=PA52&pg=PA51#v=onepage |date=20141001112247 }} at [[Google_Books|Google Books]].</ref>。他把它稱為維他命D，因為它是第四個被命名的維他命<ref>{{cite news |url=https://www.thestar.com/printarticle/239341 |title=Age-old children's disease back in force |first=Suzanne |last=Carere |name-list-format=vanc |work=[[Toronto_Star|Toronto Star]] |date=2007-07-25 |access-date=2010-08-24 |url-status=dead |archive-url=https://web.archive.org/web/20080517044348/http://www.thestar.com/printArticle/239341 |archive-date=2008-05-17 |dead-url=no }}</ref><ref>{{cite book |vauthors=McClean FC, Budy AM |chapter=Vitamin A, Vitamin D, Cartilage, Bones, and Teeth |title=Vitamins and Hormones |chapterurl={{google books |plainurl=y |id=gGb7vm2SapcC  |pages = 51}} |date = 1964-01-28 | publisher = Academic Press | isbn = 978-0-12-709821-0 | volume = 21 | pages = 51–52}}</ref>。最初人們並未意識到，它與其他維他命不同，維他命D可以由人體透過暴露於紫外線下合成。

1925年，當研究人員利用光照射7-脫氫膽固醇時，確立利用光照射7-脫氫膽固醇時，會產生了一種[[親脂性|親脂性]]維他命（現在稱為維他命D<sub>3</sub>）<ref name="Wolf_2004"/>。{{le|阿爾弗雷德·法比安·赫斯|Alfred Fabian Hess}}指出：「光等於維他命D<ref>{{cite web |url=http://vitamind.ucr.edu/about/ |title=History of Vitamin D |publisher=University of California at Riverside |date=2011 |access-date=2014-05-09 |archive-date=2017-10-16 |archive-url=https://web.archive.org/web/20171016014311/http://vitamind.ucr.edu/about/ |dead-url=yes }}</ref><ref>[http://www.beyonddiscovery.org/content/view.txt.asp?a=414 "Unraveling The Enigma Of Vitamin D"] {{Wayback|url=http://www.beyonddiscovery.org/content/view.txt.asp?a=414 |date=20130204111737 }} [[United_States_National_Academy_of_Sciences|United States National Academy of Sciences]]</ref>。」德國[[哥廷根大学|格丁根大學]]的[[阿道夫·溫道斯|阿道夫·溫道斯]]，他於1928年因研究固醇的組成及其與維他命的關係而獲得[[诺贝尔化学奖|諾貝爾化學獎]]，以表彰其在研究固醇與維他命之間關係的工作<ref>{{cite web |url=http://nobelprize.org/nobel_prizes/chemistry/laureates/1928/windaus-bio.html |title=Adolf Windaus – Biography |publisher=Nobelprize.org |date=2010-03-25 |access-date=2010-03-25 |archive-date=2018-07-24 |archive-url=https://web.archive.org/web/20180724002502/https://www.nobelprize.org/nobel_prizes/chemistry/laureates/1928/windaus-bio.html |dead-url=no }}</ref>。1929年，位於倫敦漢普斯特德的{{le|國立醫學研究所（NIMR）|National Institute for Medical Research}}的一個小組正在研究目前尚未清楚的維他命D結構，以及類固醇的結構。他們跟[[約翰·伯頓·桑德森·霍爾丹|約翰·伯頓·桑德森·霍爾丹]]、[[J·D·伯納爾|J·D·伯納爾]]及[[多萝西·霍奇金|桃樂絲·霍奇金]]進行會議討論了可能的結構，這有助於使小組團結起來。X光晶體學分析顯示甾醇分子呈扁平狀，這跟溫道斯所領導的德國團隊提議的有所不同。1932年，奧托·羅森海姆（Otto Rosenheim）和哈羅德·金（Harold King）發表了一篇論文，提出了甾醇和膽汁酸的結構，這個論點立即被接受<ref>{{cite journal |vauthors=Rosenheim O, King H |title=The Ring-system of sterols and bile acids. Part II |journal=J. Chem. Technol. Biotechnol. |volume=51 |pages=954–7 |year=1932 |doi=10.1002/jctb.5000514702 |issue=47}}</ref>。團隊成員{{le|羅伯特·本尼迪·鮑迪永|Robert Benedict Bourdillon}}、奧托·羅森海姆、哈羅德·金及{{le|肯尼斯·卡洛|Kenneth Callow}}之間的非正式學術合作非常有成效，並導致維他命D的隔離和表徵的發現<ref>{{ cite journal | vauthors = Askew FA, Bourdillon RB, Bruce HM, Callow RK, ((St. L. Philpot J)), Webster TA | title = Crystalline Vitamin D |journal = Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character |volume = 109 | issue = 764 | pages = 488–506 | doi = 10.1098/rspb.1932.0008 | year = 1932 | jstor=81571| doi-access = free }}</ref>。當時，[[英國醫學研究委員會|英國醫學研究委員會]]的政策不是針對專利發現，而是認為醫學研究的結果應該向所有人開放。在1930年代，溫道斯進一步闡明了維他命D的化學結構<ref name=Hirsch2011>{{cite book |author=Hirsch AL |chapter=Industrial aspects of vitamin D |title=Vitamin D |year=2011 |veditors=Feldman DJ, Pike JW, Adams JS |publisher=Academic Press  |pages = 73 | chapter-url ={{google books |plainurl=y |id=w7hMAFmsM84C  |pages = 73}} | isbn = 978-0-12-387035-3 }}</ref>。

1923年，[[威斯康辛大學麥迪遜分校|威斯康辛大學麥迪遜分校]]的美國生物化學家{{le|哈利·斯汀博克|Harry Steenbock}}的研究顯示，紫外線照射增加了食物和其他有機物質中維他命D的含量<ref name="isbn0-8047-4920-5">{{cite book |vauthors=Ziedonis AA, Mowery DC, Nelson RR, Bhaven NS |title=Ivory tower and industrial innovation: university-industry technology transfer before and after the Bayh-Dole Act in the United States |publisher=Stanford Business Books |year=2004 |pages=39–40 |isbn=978-0-8047-4920-6 |url={{google books |plainurl=y |id=sCscGlm2Q8YC  |pages = 39}} }}</ref><ref>{{cite book |author=Arvids A. Ziedonis; Mowery, David C.; Nelson, Richard R.; Bhaven N. Sampat |title=Ivory tower and industrial innovation: university-industry technology transfer before and after the Bayh-Dole Act in the United States |publisher=Stanford Business Books |location=Stanford, Calif |year=2004 |pages= [http://books.google.com/books?id=sCscGlm2Q8YC&pg=PA3939–40] |isbn=0-8047-4920-5}}</ref>。在照射囓齒動物的食物後，斯汀博克發現囓齒動物的佝僂病得到治癒。維他命D缺乏是已知佝僂病的已知病因。斯汀博克於是利用自己的$300美元為其發明申請了專利。他把其技術用於食物，最讓人難忘的是用於牛奶。他的專利於1945年到期時，佝僂病在美國幾乎被淘汰了<ref name="Marshall2010">{{cite book |first=James |last=Marshall | name-list-format = vanc |title=Elbridge a Stuart: Founder of Carnation Company |url={{google books |plainurl=y |id=6fICTwEACAAJ}}|date=September 2010|publisher=Kessinger Publishing|isbn=978-1-164-49678-6}}</ref><ref>{{cite book|author = Marshall, James|year = 2005|title = Elbridge A. Stuart Founder of the Carnation Company|publisher = Kessinger Publishing|page = 235|isbn = 978-1417988839 }}</ref>。

1969年，在研究了腸道細胞的核碎片後，馬克·考斯勒（Mark Haussler）與{{le|安東尼·W·諾曼|Anthony W. Norman}}鑑定了一種稱為{{le|維他命D受體|Vitamin D receptor}}的維他命D特異性結合蛋白<ref>{{cite journal | vauthors = Haussler MR, Norman AW | title = Chromosomal receptor for a vitamin D metabolite | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 62 | issue = 1 | pages = 155–62 | date = January 1969 | pmid = 5253652 | pmc = 285968 | doi = 10.1073/pnas.62.1.155 | bibcode = 1969PNAS...62..155H }}</ref>。在1971–72年，維他命D進一步代謝以活性形式被發現。在肝臟中，維他命D被發現轉化為骨化二醇。骨化二醇然後被腎臟轉化為骨化三醇 — 維他命D於生物學上的活性形式<ref name="autogenerated2799" />。骨化三醇作為一種激素在血液中循環，調節血液中鈣和磷酸鹽的濃度，促進骨骼的健康生長和重塑。維他命D代謝物—骨化二醇和骨化三醇，分別由東尼·諾曼及其同事於{{le|赫克托·德盧卡|Hector DeLuca}}實驗室中的跟{{le|米高·F·霍利克|Michael F. Holick}}領導的競賽團隊於實驗中確定<ref name="pmid4323790">{{cite journal | vauthors = Holick MF, Schnoes HK, DeLuca HF | title = Identification of 1,25-dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 68 | issue = 4 | pages = 803–4 | date = April 1971 | pmid = 4323790 | pmc = 389047 | doi = 10.1073/pnas.68.4.803 | bibcode = 1971PNAS...68..803H }}</ref><ref name="pmid4325863">{{cite journal | vauthors = Norman AW, Myrtle JF, Midgett RJ, Nowicki HG, Williams V, Popják G | s2cid = 35236666 | title = 1,25-dihydroxycholecalciferol: identification of the proposed active form of vitamin D3 in the intestine | journal = Science | volume = 173 | issue = 3991 | pages = 51–4 | date = July 1971 | pmid = 4325863 | doi = 10.1126/science.173.3991.51 | bibcode = 1971Sci...173...51N }}</ref><ref>{{cite journal | vauthors = Holick MF, DeLuca HF, Avioli LV | title = Isolation and identification of 25-hydroxycholecalciferol from human plasma | journal = Archives of Internal Medicine | volume = 129 | issue = 1 | pages = 56–61 | date = January 1972 | pmid = 4332591 | doi = 10.1001/archinte.1972.00320010060005 }}</ref>。

== 科研 ==
維他命D缺乏症在歐洲人口中普遍存在著<ref>{{cite journal | vauthors = Cashman KD, Dowling KG, Škrabáková Z, Gonzalez-Gross M, Valtueña J, De Henauw S, Moreno L, Damsgaard CT, Michaelsen KF, Mølgaard C, Jorde R, Grimnes G, Moschonis G, Mavrogianni C, Manios Y, Thamm M, Mensink GB, Rabenberg M, Busch MA, Cox L, Meadows S, Goldberg G, Prentice A, Dekker JM, Nijpels G, Pilz S, Swart KM, van Schoor NM, Lips P, Eiriksdottir G, Gudnason V, Cotch MF, Koskinen S, Lamberg-Allardt C, Durazo-Arvizu RA, Sempos CT, Kiely M | display-authors = 6 | title = Vitamin D deficiency in Europe: pandemic? | journal = The American Journal of Clinical Nutrition | volume = 103 | issue = 4 | pages = 1033–44 | date = April 2016 | pmid = 26864360 | pmc = 5527850 | doi = 10.3945/ajcn.115.120873 }}</ref>。歐洲正在研究與疾病發生率和飲食建議、食物強化、維他命D補充和日間少量暴露於陽光下的相關政策來評估維他命D的攝入量<ref name=spiro/>。除了VDR激活外，各種不同的作用機制正在研究中，例如透過[[刺蝟信號通路|刺蝟]]的[[訊息傳遞_(生物)|生物訊息傳遞]]，那是一種有關激素的[[形態發生|形態發生]]<ref name=Sarkar2010 />。

關於維他命D干預益處的證據出現互相矛盾<ref name="pmid28163705">{{cite journal | vauthors = Dankers W, Colin EM, van Hamburg JP, Lubberts E | title = Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential | journal = Frontiers in Immunology | volume = 7 | issue =  | pages = 697 | year = 2016 | pmid = 28163705 | pmc = 5247472 | doi = 10.3389/fimmu.2016.00697 }}</ref>，有一種觀點認為日曬的每天攝入量為4,000-12,000個IU，同時血清中的25-羥基維他命D水平為40-80ng/mL<ref name="Heaney_Holick_2011"/>，而另一種觀點認為血清濃度高於50ng / mL是不合理的<ref name="Heaney_Holick_2011">{{cite journal | vauthors = Heaney RP, Holick MF | title = Why the IOM recommendations for vitamin D are deficient | journal = Journal of Bone and Mineral Research | volume = 26 | issue = 3 | pages = 455–7 | date = March 2011 | pmid = 21337617 | doi = 10.1002/jbmr.328 | s2cid = 41510449 }}</ref><ref name=holick2011 />。

截至2013年的證據，證據都不足以確定維他命D是否對癌症風險會有影響<ref>{{Cite web |url=https://www.cancer.gov/about-cancer/causes-prevention/risk/diet/vitamin-d-fact-sheet#q4 |title=How is vitamin D being studied now in clinical cancer research? |publisher=National Cancer Institute, US National Institutes of Health |date=2013-10-21 |accessdate=2020-08-22 |archive-date=2015-02-13 |archive-url=https://web.archive.org/web/20150213152515/http://www.cancer.gov/cancertopics/factsheet/prevention/vitamin-D#q4 |dead-url=no }}</ref>。[[國家衛生院_(美國)|美國國家衛生研究院]]的膳食補充劑辦公室於2014年建立了一項維他命D計劃，以追踪當時的研究並向消費者提供教育<ref>{{Cite web |url=https://ods.od.nih.gov/Research/VitaminD.aspx |title=ODS Vitamin D Initiative |publisher=Office of Dietary Supplements, US National Institutes of Health |date=2014 |accessdate=2020-08-22 |archive-date=2021-01-26 |archive-url=https://web.archive.org/web/20210126003225/https://ods.od.nih.gov/Research/VitaminD.aspx |dead-url=no }}</ref>。他們進一步指出：「這些作用的大多數證據來自體外、動物和流行病學研究，而不是被認為更具決定性的隨機臨床試驗。直至此類試驗進行之前，將會進行現有關於公共衛生和患者護理問題牽連證據的討論<ref name=NIH2016 />。」一些初步研究把低水平的維他命D與生命後期的疾病聯繫在一起<ref>{{Cite book |vauthors=Pyrżak B, Witkowska-Sędek E, Krajewska M, Demkow U, Kucharska AM |chapter=Metabolic and immunological consequences of vitamin D deficiency in obese children |volume=840 |pages=13–9 |year=2015 |pmid=25315624 |doi=10.1007/5584_2014_81 |isbn=978-3-319-10249-8 |series=Advances in Experimental Medicine and Biology |title=Body Metabolism and Exercise}}</ref>。一項綜合分析發現老年人的死亡率降低<ref name=Bj2014/>。另一項涵蓋超過350,000人的綜合分析得出結論，在未經揀選的社區居民中個人補充維他命D不會使骨骼（總骨折）或非骨骼結果（心肌梗塞、缺血性心臟病、中風、腦血管疾病、癌症）減少了15％以上，而且具有類似設計的進一步研究都不太可能改變這些結論<ref name=Futil2014/>。

2019年的綜合分析發現，同時服用鈣和維他命D可能會增加中風的風險<ref>{{cite journal | vauthors = Khan SU, Khan MU, Riaz H, Valavoor S, Zhao D, Vaughan L, Okunrintemi V, Riaz IB, Khan MS, Kaluski E, Murad MH, Blaha MJ, Guallar E, Michos ED | display-authors = 6 | title = Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes: An Umbrella Review and Evidence Map | journal = Annals of Internal Medicine | volume = 171 | issue = 3 | pages = 190–198 | date = August 2019 | pmid = 31284304 | pmc = 7261374 | doi = 10.7326/m19-0341 }}</ref>。另外，他們亦於2020年的審查中意識到，人們認識到越來越多的研究表明，維他命D在預防和治療1型和2型糖尿病、葡萄糖不耐症、高血壓、多發性硬化症和其他醫學疾病中可能發揮著某些作用。然而，他們得出的結論是，除了在骨骼健康方面有著更為積極的發現以外，現有證據都不足或太矛盾，以致無法確認維他命D在這些情況下的有效性<ref name="NIH-ODS-2020">{{cite web |title=Office of Dietary Supplements - Vitamin D |url=https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/ |website=ods.od.nih.gov |accessdate=2020-10-31 |language=en |archive-date=2016-12-31 |archive-url=https://web.archive.org/web/20161231073744/https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/ |dead-url=no }}</ref>。

=== COVID-19 ===
維他命D缺乏症已被證明可能會增加患上嚴重呼吸道感染的風險<ref name=bmj2017/>。在[[2019冠状病毒病疫情|2019冠状病毒病疫情]]期間，這在2020年引起了人們對該潛力重新產生興趣。一個對27項出版物的系統評價和綜合分析發現，維他命D缺乏症跟更高機會感染COVID-19的可能性並沒有關聯，但發現到維他命D缺乏症跟疾病的嚴重程度之間存在著正相關的關係，包括了住院率和死亡率的增加<ref name="pmid33146028">{{cite journal | vauthors = Pereira M, Dantas Damascena A, Galvão Azevedo LM, de Almeida Oliveira T, da Mota Santana J | title = Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis | journal = Critical Reviews in Food Science and Nutrition | pages = 1–9 | date = November 2020 | pmid = 33146028 | doi = 10.1080/10408398.2020.1841090 }}</ref>。

2020年6月，美國[[美國國立衛生研究院|美國國立衛生研究院]]發現沒有足夠的證據建議或反對使用維他命D補充劑作為專門預防或治療COVID-19<ref name="NIH2020-D-C19">{{Cite web|title=Vitamin D {{!}} Coronavirus Disease COVID-19|url=https://www.covid19treatmentguidelines.nih.gov/adjunctive-therapy/vitamin-d/|access-date=2020-10-03|website=COVID-19 Treatment Guidelines (US Centers for Disease Control and Prevention)|language=en|archive-date=2021-01-27|archive-url=https://web.archive.org/web/20210127192830/https://www.covid19treatmentguidelines.nih.gov/adjunctive-therapy/vitamin-d/|dead-url=no}}</ref>。同月，{{le|英國國家健康與護理卓越學院|National Institute for Health and Care Excellence}}發現沒有證據支持或反對服用維他命D補充劑為專門預防或治療COVID-19<ref name="NICE2020">{{cite web |title=Advisory statement on likely place in therapy {{!}} COVID-19 rapid evidence summary: vitamin D for COVID-19 {{!}} Advice {{!}} NICE |url=https://www.nice.org.uk/advice/es28/chapter/Advisory-statement-on-likely-place-in-therapy |website=www.nice.org.uk |access-date=2020-10-02 |archive-date=2020-12-18 |archive-url=https://web.archive.org/web/20201218103357/https://www.nice.org.uk/advice/es28/chapter/Advisory-statement-on-likely-place-in-therapy |dead-url=no }}</ref>。這兩個組織都提出了一些建議，而這些建議是應繼續適用先前出於其他原因而補充維他命D建議（如骨骼和肌肉健康）。兩個組織都指出，由於COVID-19大流行期間的日照量較低，可能有更多的人需要補充劑<ref name="NIH2020-D-C19" /><ref name="NICE2020" />，而英國國民保健署（NHS）已為COVID-19高危人群免費提供每天維他命D補充劑<ref>{{cite web |title=Get vitamin D supplements if you're at high risk from coronavirus (COVID-19) |url=https://www.nhs.uk/conditions/coronavirus-covid-19/people-at-higher-risk/get-vitamin-d-supplements/ |website=nhs.uk |access-date=2020-11-30 |language=en |date=2020-11-27 |archive-date=2021-02-02 |archive-url=https://web.archive.org/web/20210202090515/https://www.nhs.uk/conditions/coronavirus-covid-19/people-at-higher-risk/get-vitamin-d-supplements/ |dead-url=no }}</ref>。

COVID-19的主要併發症是[[急性呼吸窘迫症候群|急性呼吸窘迫綜合症]]（ARDS），可能是由於維他命D缺乏症而加劇<ref name="Quesada-Gomez">{{cite journal | vauthors = Quesada-Gomez JM, Entrenas-Castillo M, Bouillon R | title = Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166 | journal = The Journal of Steroid Biochemistry and Molecular Biology | volume = 202 | pages = 105719 | date = September 2020 | pmid = 32535032 | doi = 10.1016/j.jsbmb.2020.105719 | pmc = 7289092 }}</ref>，但這個關聯並不明確與冠狀病毒感染有關<ref name="Quesada-Gomez"/>。不同國家將於2020年進行許多試驗，以探討使用維他命D作為預防和治療SARS-CoV-2感染的潛力<ref name="Quesada-Gomez"/><ref name="vitD-clintrials"/>。

== 参考文献 ==
{{Reflist|colwidth=30em}}

== 衍生阅读 ==
{{refbegin}}
* Ross, A.C/Taylor, C.L./Yaktine, A.L./Valle, H.B.D. (editors, 2011) [http://www.nap.edu/catalog.php?record_id=13050 Dietary Reference Intakes for Calcium and Vitamin D]{{Wayback|url=http://www.nap.edu/catalog.php?record_id=13050 |date=20140909000908 }}. National Academies Press. ISBN 978-0-309-16394-1
* Rubin, A.L. (2011). ''Vitamin D for Dummies''. Wiley Publishing. ISBN 978-0-470-89175-9
* [http://ods.od.nih.gov/factsheets/vitamind/ Dietary Supplement Fact Sheet: Vitamin D]{{Wayback|url=http://ods.od.nih.gov/factsheets/vitamind/ |date=20120213172750 }} from the U.S. [[National_Institutes_of_Health|National Institutes of Health]]
* [http://www.nature.com/news/2011/110706/pdf/475023a.pdf Disagreement among experts about the correct vitamin D dose.] {{Wayback|url=http://www.nature.com/news/2011/110706/pdf/475023a.pdf |date=20200803081923 }} (Nature News, July 6, 2011)
{{refend}}

{{-}}
{{必需维生素}}
{{抗银屑病药}}

[[Category:维生素D|]]